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Heart failure is the leading cause of death worldwide.   In 2013, the American 
Heart Association estimated that one American will die of cardiovascular disease every 
39 seconds.  While heart transplantation is the most viable treatment option, the limited 
availability of donor hearts has necessitated the search for treatment alternatives such as 
the use of adult stem cells for cardiac repair and regeneration.  Following myocardial 
infarction (MI), the inflammatory cardiac microenvironment, limited survival of 
stem/progenitor cells, myocardial scarring and fibrosis affect cardiac regeneration.  This 
dissertation examines adult stem cell based approaches for cardiac regeneration by 
studying the effect of i) H2O2- mediated oxidative stress on mesenchymal stem cells, ii) 
Notch1 activation in cardiac progenitor cells using a self-assembling peptide hydrogel 
containing the Notch1 ligand mimic RJ in vitro and functional consequences in a rat 
model of MI.   
Levels of oxidative stress are elevated in the infarcted heart.  Delivery of 
mesenchymal stem cells (MSCs) to the infarcted heart has resulted in modest 
improvements in function.  Hence, we sought to determine if oxidative stress can regulate 
MSC gene expression by subjecting MSCs to varying levels of oxidative stress (through 
H2O2 or Glucose oxidase).  We found that H2O2 and Glucose oxidase regulate cardiogenic 
gene expression in MSCs through Notch1 signaling. 
Notch1 signaling plays an important role in cardiac development, stem cell 
survival and differentiation.  Mechanical force exerted by ligand bound to Notch1 
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receptor is essential for activation of Notch1 signaling.  So we designed a 3D self-
assembling peptide hydrogel that incorporated a peptide mimic of the Notch1 ligand 
Jagged1 (RJ).  Utilizing a reporter cell line, we demonstrate the synergistic effect of 
hydrogel stiffness and presence of Notch1 ligand RJ on Notch1 activation.  We also 
found that hydrogel stiffness dependent Notch1 activation differentially regulates 
cardiogenic gene expression in rat cardiac progenitor cells (CPCs).  Culture of CPCs in 
RJ-containing hydrogels also exerted paracrine effects on endothelial cells and myocytes 
in vitro.  In rats subjected to MI, intramyocardial delivery of CPCS in 2RJ hydrogels 
promoted cardiac repair through increased ejection fraction, stroke work and decreased 
fibrosis on day 21 after treatment.  
 Through these approaches, the central hypothesis that modulation of stem cell 
response using cues such as oxidative stress and activation of Notch1 signaling can 







Cardiovascular disease is a global healthcare burden.  Apart from heart 
transplantation, pharmacological interventions, cardiac- assisted devices and lifestyle 
modifications have improved the quality of life of people with cardiovascular disease.  
Although these treatments maintain cardiac function, new therapies that promote cardiac 
repair and regeneration are needed.  These include enhancement of endogenous myocyte 
and progenitor cell responses as well as transplantation of culture expanded autologous 
progenitor cells in suitable cell delivery vehicles.  
 
1.1 MOTIVATION 
Cardiovascular disease is the leading cause of global morbidity and mortality.  The 
AHA estimates that 1 in 3 Americans will suffer from cardiovascular disease during their 
lifetime (1).  Although heart transplantation is the most viable treatment option, limited 
availability of donor hearts has necessitated the need for treatment alternatives.  Several 
strategies aimed at improving acute cardiac function by utilizing pharmacological 
inhibitors and implanted devices have met with moderate success.  However, improving 
cardiac function through myocardial regeneration by triggering the resident cardiac cells 
or adult tissue resident stem cells needs to be further investigated and developed as a 
potential clinical treatment.  Studies have demonstrated different routes for delivery of 
stem/progenitor cells to specific organs by implantation on novel scaffolds ranging from 
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synthetic to biologically inspired materials.  Though these studies have shown modest to 
significant functional improvements, there is a need for better understanding of the 
precise molecular pathways responsible for the observed functional benefits.  
Furthermore, the microenvironment in which the stem cells are implanted holds great 
promise as a source of cues to direct survival, proliferation and differentiation of stem 
cells.  This is especially important as clinical trials using bone marrow-derived 
mesenchymal stem cells (MSCs) and heart-derived cardiac progenitor cells (CPCs) 
demonstrate modest functional improvements.  However, these outcomes can be 
improved by promoting cardiac retention and differentiation of implanted progenitor cells 
to contribute directly to the regenerative process.  The myocardial environment following 
an infarction has elevated levels of reactive oxygen species (ROS) that may greatly 
influence the cardiogenic differentiation of endogenous or implanted progenitor cells.  
Many adult cells also alter their Notch signaling during disease states (2, 3), and no link 
has been made between oxidative stress and Notch signaling to date.  The motivation for 
this study stems from the increased survival rates in patients following infarction who 
require cardiac therapies that promote sustained myocardial repair and regeneration.  
Moreover, the improvements in function following administration of CPCs in Phase I 
clinical trials in patients with cardiac disease provides further impetus to find ways to 
engineer, deliver and retain the CPCs in the infarcted heart and direct stem cell fate in 
vivo. 
 
1.2 SPECIFIC AIMS 
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Heart failure due to myocardial infarction (MI) is a major source of global morbidity 
and mortality.  Inadequate blood supply to the heart followed by death of cardiac 
myocytes in the ischemic region of the heart leads to MI.  While reperfusion and 
transplantation surgeries have been successful in treating patients with MI to a significant 
extent, the use of stem cells to regenerate the infarcted heart is a promising emerging 
alternative.  Stem cells of different origins have been shown to improve cardiac function 
in experimental models of cardiovascular diseases (4-6).  Adult stem cells are an 
attractive therapeutic approach due to the ease of isolation and culture expansion as well 
as fewer ethical issues and lessened teratoma fears compared to embryonic sources.  
Adult bone marrow-derived mesenchymal stem cells (MSCs) and heart-derived cardiac 
progenitor cells (CPCs) are multipotent, undifferentiated tissue-resident cells.  Injection 
of MSCs or CPCs into infarcted hearts has resulted in cardiogenic differentiation and 
acute functional improvements (7-11)}.  However, the mechanism by which the 
implanted cells improve function in the infarcted heart is still not fully understood. 
Pathophysiological levels of oxidative stress elicit stem cell specific responses (12).  
In addition to redox levels, stem cell differentiation is also strongly influenced by Notch 
signaling (13).  Notch knockouts are embryonic lethal due to blood vessel and heart 
defects (14).  While, the effects of Notch signaling on stem cell differentiation are well 
studied, the interplay between oxidative stress and Notch signaling is unknown.  Phase I 
clinical trials of cardiac progenitor cell therapy in patients with cardiovascular diseases 
have demonstrated promising outcomes (15, 16).  Moreover, Notch signaling has been 
shown to precede cardiac regeneration in zebrafish and regulate CPC function (10, 17).  
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Based on these scientific advancements, this dissertation focusses on developing an adult 
stem cell based therapy for myocardial infarction (Figure 1). 
 
Figure 1: Schematic representing overall goal of the dissertation study. 
Specific Aim 1: Investigate the effect of H2O2 and Notch1 signaling on cardiogenic 
differentiation of MSCs and CPCs.   
We hypothesized that adult stem cell differentiation is redox-sensitive and the 
balance between redox signaling and Notch1 activation modulates stem cell gene 
expression.  Rat bone marrow-derived MSCs or heart-derived CPCs were treated with a 
range of H2O2 concentrations (0.1-100µM) for 1 week or Glucose oxidase (GOX, 0-
5mU/ml) for 48h.  The effect of H2O2 or GOX- mediated oxidative stress on cardiogenic 




Specific Aim 2: Determine the effect of hydrogel-immobilized Notch1 ligand Jagged1 on 
Notch1 activation in CPCs.   
We hypothesized that hydrogel stiffness and the peptide mimic of the Notch1 
ligand Jagged1, RJ could modulate Notch1 signaling.  The effect of hydrogel stiffness 
and ligand RJ on Notch1 activation was studied using a Notch1 reporter system.  CPCs 
were also cultured in a self-assembling peptide hydrogel containing RJ and the effect on 
cardiogenic gene expression was examined in vitro. 
Specific Aim 3: Use self-assembling peptide hydrogels containing RJ to direct CPC 
function in vivo following an infarction.   
We hypothesized that delivery of CPCs in a bioactive hydrogel containing a 
ligand to activate Notch1 signaling could lead to improvements in cardiac function after  
myocardial infarction.  The effect of intramyocardial delivery of CPCs in empty, 
scrambled or RJ-containing self-assembling peptide nanofiber hydrogels was investigated 
through pressure-volume hemodynamics and whole-animal imaging.  
The results from these studies have demonstrated i) how oxidative stress and 
Notch1 activation regulate cardiogenic gene expression in MSCs either separately or 
synergistically and ii) a new  method to direct CPC function in a hydrogel containing 
signals for Notch1 activation. These results may have broad clinical applications in 





CHAPTER 2  
BACKGROUND 
 
2.1 MYOCARDIAL INFARCTION 
The heart is the first organ to develop during embryogenesis and plays a central 
role during both development and adulthood, because it is required for pumping nutrients 
and oxygen to all organs.  However, partial or complete loss of blood supply due to 
occlusion of the coronary artery leads to myocardial infarction and the subsequent loss of 
ventricular function ultimately causes heart failure.  To maintain pump function, the 
viable myocardium undergoes ventricular dilation and wall thinning by side-to-side 
slippage of myocytes.  This leads to infarct expansion from the apex with extensive 
myocyte death in the infarct area and myocyte hypertrophy in non-infarcted regions along 
with increased wall stress (18).  These changes that result in alterations of existing 
structures after MI constitute cardiac remodeling.  The long term consequences of these 
structural changes also depend on the extent of fibrosis.  Acute inflammation following 
MI increases local TGFβ that promotes collagen synthesis by fibroblasts (19).  Although 
acute reparative fibrosis that results in scar formation stabilizes the infarct, over time the 
stiffened ventricular wall impairs efficient pump function.  Hence, morphological 
alternations that support acute remodeling may improve function, but over time, scar 
formation and comorbidities lead to end stage heart failure and death (20).   
The American Heart Association estimates that one person will die of 
cardiovascular disease every 39 seconds in the United States (1).  With heart disease 
being the leading cause of death worldwide and the limited availability of donor hearts 
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for transplantation, there is a strong need to develop alternative therapies ranging from 
assisted heart devices, small molecule drugs to stem cell based cardiac repair for 
improving cardiac function.   
 
2.2 OXIDATIVE STRESS IN THE HEART 
Our preliminary data and extensive published studies demonstrate significant 
increases in level of reactive oxygen species (ROS) almost immediately following acute 
myocardial infarction (MI) (21).  While the source of these radicals is unclear (invading 
inflammatory cells, resident cells), it is evident that elevated levels of oxidative stress 
have deleterious effects on the cardiovascular system and play a prominent role in the 
pathophysiology of heart failure (22).  Converging lines of evidence for involvement of 
ROS in cardiac remodeling and failure include: 1) studies demonstrating an association 
between increased oxidative stress and heart failure (23), 2) levels of endogenous 
scavengers such as catalase and superoxide dismutase are downregulated following 
infarction  (24); 3) antioxidant based interventional treatments suggest a role for ROS in 
MI (25) and 4) genetically modified animal models have provided direct molecular 
evidence for the role of ROS in mediating post-MI remodeling in mice (26, 27).  These 
studies demonstrate that reduction of oxidative stress in the ischemic heart leads to 
reduced apoptosis, scar formation, and inflammatory molecule release, all of which may 
modulate the efficacy of delivered therapeutics. 
 
2.2.1 Influence of oxidative stress on stem cells 
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The levels of reactive oxygen species (ROS) modulate the balance between physiological 
and pathophysiological cardiac microenvironment at the infarct site.  Potential sources of 
ROS in the myocardium include the NADPH oxidases of fibroblasts and infiltrating 
inflammatory cells, as well as the myocytes themselves.  Ischemic injury further elevates 
ROS production in these cells which influences differentiation of endogenous or 
implanted stem cells at the infarct.  Physiological H2O2 levels increase cardiogenic 
differentiation of embryonic stem (ES) cells, while pathophysiological levels induce 
apoptosis in ES-derived myocytes (28).  Moreover, the effect of oxidative stress on stem 
cells is varied ranging from promotion of neural stem cell differentiation (12), to 
inhibition of MSC adhesion to the infarcted myocardium (29).   
 
2.3 CARDIAC REGENERATION 
The long standing paradigm that the adult mammalian heart is a post-mitotic 
organ has been challenged by identification of cardiomyocyte proliferation and resident 
cardiac stem cells in the heart (30-32).  However, the limited regenerative capacity of the 
human heart is evident when compared to lower organisms such as the zebrafish and 
newt in which resection of ~20% the heart results in complete regeneration within 2 
months.  By a process of dedifferentiation of cells adjacent to the injury followed by cell 
proliferation, new myocytes are formed that integrate functionally with the pre-existing 
myocardium along with minimal evidence of injury (33).  Mice can also regenerate the 
heart after injury during embryonic development and 1 week after birth by mechanisms 
similar to newts and zebrafish (34).  The therapeutic challenge to promote such 
regeneration in humans after infarction is compounded by the loss of >1billion (~25% of 
the total)  myocytes and extensive scar formation (35).  Hence, development of therapies 
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aimed at delivering exogenous stem cells or promoting endogenous stem cell responses 
with long-term tissue integration will be critical to achieve cardiac regeneration in 
humans. 
 
2.3.1 Mesenchymal stem cells for cardiac regeneration 
There is ample evidence of the beneficial effects of bone-marrow derived 
mesenchymal stem cells (MSCs) for treating myocardial infarction in small and large 
animal studies (36-38).   Whereas MSCs are capable of differentiation to multiple 
lineages, when delivered to the heart after acute MI, cardiogenic (all cell types in the 
myocardium) differentiation was noted (39).  Additionally, several studies have shown 
improvements in cardiac function following MI by mobilizing endogenous MSCs via 
injection of GM-CSF and other stem cell mobilizing factors (40).  Finally, early human 
clinical trials have demonstrated that bone marrow cell transplantation in patients is safe 
with modest, yet significant, improvements in cardiac performance after MSC 
administration (41, 42).  Despite potential advantages in the use of bone marrow derived 
stem cells to treat heart failure, patients who received autologous bone marrow cells had 
<5% increase in ejection fraction (43-46).  However, parameters indicative of long term 
improvement such as infarct remodeling and exercise capacity showed positive 
improvement at 6 month follow up (47).  Interestingly, severity of infarction correlated 
with maximum therapeutic benefit (46).  Evidence from studies in animal models suggest 
the predominant mechanism by which bone marrow derived cells exert modest beneficial 
effects to be through paracrine factors and fusion with myocytes rather than actual 
transdifferentiation (48).  It is interesting to note that these studies had positive data with 
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very small retention of administered cells, and cardiogenic differentiation of the 
remaining population is estimated to be quite low with the predominant effect thought to 
be paracrine.   
 
2.3.2 Cardiac progenitor cells for cardiac regeneration 
Myocardial infarction and other cardiovascular diseases have poor prognosis due 
to lack of sufficient endogenous regeneration in the heart.  However, in the past few 
years, the identification of stem/progenitor cell populations in small niches within the 
heart with surface expression of c-Kit, Sca1 (Stem cell Antigen 1) and MDR1 (multidrug 




 cells from the heart of adult 
mice which were clonogenic, self-renewing and differentiated into cardiac lineages (31).  
Oh and colleagues isolated Sca1
+
 CPCs from adult mice with cardiogenic potential (50).  
A side population of cells that efflux Hoechst dye and express the ATP-binding cassette 
transporter Abcg2 has also been identified.  These cells proliferate, differentiate and 
adopt cardiac cell fates (51).  Cardiosphere-derived cells (CDCs) are obtained by 
culturing cells from heart tissue in suspension cultures.  These CDCs are a heterogenous 
cell population with expression of cKit by cells in the core and expression of endothelial 
genes Flk1 and CD31 by cells in the periphery (52).  Although these progenitor cells 
differ in the cellular and phenotypic characteristics, the potential for use in cardiac cell 
therapy has prompted extensive studies in animal models.  Reports indicate the ability of 
CPCs to regenerate the myocardium and improve cardiac function in rat and canine 
models of MI (31, 53).  Isolation of c-Kit
+
 cardiac stem cells from humans has promoted 
the extensive study of these cells for myocardial regeneration (32).  Taken together, the 
different stem cells present in the heart could differentiate in vivo to endothelial cells, 
11 
 
vascular smooth muscle cells, cardiomyocytes or combination of all three cell types that 
constitute the heart.   
Based on the promising results from the pre-clinical studies discussed above and 
to address the critical need for alternate treatments for patients with heart failure, the 
safety and efficacy of the progenitor cells (CPCs, CDCs) have been tested in Phase I 
clinical trials.  Moreover, the presence of CPCs in the heart, the expression of certain 
early cardiogenic genes, and the ability to differentiate into cells of the cardiogenic 
lineage in vitro and in vivo makes CPCs a more suitable cell type for cardiac regeneration 
than other adult stem cell sources (54).  The SCIPIO (Stem Cell Infusion in Patients with 
Ischemic Cardiomyopathy) is a Phase I, randomized, open-label trial utilizing autologous 
cKit+ cardiac stem cells (CSCs) from patients undergoing coronary artery bypass grafting 
(CABG) for ischemic cardiomyopathy (15).    The trial achieved the primary goal of 
demonstrating safety and feasibility of the procedure.  Following introacoronary 
administration of CSCs, a remarkable improvement in both global and regional cardiac 
function was observed in patients at 4 and 12 months following CSC infusion.  In the 
randomised CADUCEUS (CArdiosphere-Derived aUtologous stem CElls to reverse 
ventricUlar dySfunction) trial, intracoronary delivery of autologous CDCs to patient with 
left ventricle dysfunction resulted in decreased infarct size, increased viable mass and 
improved regional function at 12 months following treatment (16).  These Phase I trials 





2.4 NOTCH SIGNALING IN CARDIAC DEVELOPMENT AND STEM CELLS 
 
2.4.1 Mechanism of Notch signaling 
In 1917, Thomas Morgan in The American Naturalist described a mutant 
Drosophila melanogaster strain with serrated wing ends called Notch.  In the late 1980s, 
two groups independently identified the Notch gene (55, 56).  Notch signaling is an 
evolutionarily conserved intercellular communication pathway that regulates diverse 
cellular processes, ranging from cell fate decision, differentiation, and proliferation to 
apoptosis (57).  In mammals, the Notch signaling pathway consists of 4 Notch 
transmembrane receptors (Notch1-4) and the DSL (Delta-Serrate-Lag2) family of ligands 
composed of Jagged 1,2 and Delta 1,3 and 4.  The Notch receptor has an extracellular 
domain composed of 29-36 EGF repeats followed by a linker domain.  The Notch 
intracellular domain (NICD) is composed of a trans-membrane domain, nuclear 
localization sequences, RAM domain for interaction with RBP-Jk, ankyrin repeats for 
interaction with other proteins and a PEST sequence for degradation (58).  The DSL 
ligands also contain several EGF repeats for binding to the Notch receptor.  After 
translation, the receptor undergoes fucosylation in the endoplasmic reticulum and Golgi 
apparatus.  This determines the specificity of binding to different ligands and is presented 
as a dimer on the cell surface through non-covalent linkages (59).  Transactivation of the 
Notch receptor by adjacent cell surface bound ligands of the Jagged and Delta family 
leads to downstream activation while cis-activation of Notch by binding of ligands on the 
same cell leads to ligand-receptor sequestration in the cytoplasm.  Release of the NICD 
requires 3 sequential cleavages of the receptor: the 1
st
 mediated by metalloprotease 
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TNFα-converting enzyme (TACE/ADAM17) followed by two cleavages by γ-secretase 
complex composed of presenilins and nicastrin.  Cleavage leads to nuclear translocation 
of the NICD.  The NICD binds and converts the co-repressor RBP-JK (recombinant 
signal binding protein1- for J-k) into a transcriptional activator.  This leads to canonical 
activation of the direct Notch targets of the Hes/Hey family of basic helix-loop-helix 




Figure 2: Schematic representation of Notch signaling.  Binding of the Delta/Jagged 
family of ligands to the Notch receptor on the signal receiving cell leads to release and 
translocation of the Notch intracellular domain (NICD) into the nucleus.  NICD mediates 





2.4.2 Regulation of Notch signaling 
As Notch signaling plays a critical role in several developmental processes, 
multiple levels of regulation exist such as the amount of receptors and ligand present on 
the cell surface which in turn depends on ligand/receptor endocytosis, ubiquitination, 
degradation and recycling (60).  Moreover, soluble ligands can act as signal antagonists 
(61).  Notch is regulated by lateral inhibition wherein assumption of a particular fate by a 
cell inhibits assumption of the same fate by adjacent cells.  Notch activation also leads to 
dosage dependent effects.  For example, low levels of Notch activation promote neural 
stem cell growth while high levels cause growth arrest (62).  Apart from canonical 
signaling, the effects of Notch signaling can also be amplified or attenuated by interaction 
with other signaling pathways such as Wnt, TGFb and JAK/STAT (63). 
 
2.4.3 Notch in cardiac development 
Notch signaling during development regulates cell fate and tissue formation.  In 
the developing heart, Notch signaling plays a critical role in atrioventricular canal 
formation, epithelial-to-mesenchymal transition, valve formation and ventricle and 
outflow tract development (64).  Notch1 and Notch2 are the predominant receptors in the 
developing heart while Notch3 and Notch4 are present in smooth muscle and 
endothelium respectively (65).  Loss- or gain- of function of Notch1 and the ligands and 
spontaneous mutations in humans indicate the important role for Notch in cardiac 
development.  Deregulation of Notch signaling in humans leads to congential birth 
defects such as Alagille syndrome, ventricular hypertrophy, septal defects and valve 
calcification (66).  
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2.4.4 Effects of Notch signaling 
Apart from regulating normal development and damage-induced regeneration, 
Notch signaling has also been found to promote cardiomyocyte survival (67).  Notch 
signaling also regulates stem cell fate during asymmetric cell division.  The daughter cell 
with active notch signaling remains undifferentiated while the other daughter cell adopts 
a committed fate.   This occurs through Numb, a Notch antagonist, asymmetrically 
inherited by daughter cells (58).  Notch signaling has also been identified to precede heart 
regeneration in zebrafish (17).  Notch activation has been shown to promote cardiac gene 
expression in human circulating endothelial progenitor cells through Wnt5a (68).  In mice 
subjected to myocardial infarction, activation of Notch signaling in cardiomyocytes in the 
border zone exerts a cardioprotective role in improving cardiac function (67).  
Differentiation of bone marrow-derived MSCs into cardiomyocytes is increased by 
Jagged1 mediated Notch signaling (8).  Notch promotes cardiac cell fate, function and 
gene expression in CPCs (10) while attenuating cardiac differentiation of embryonic stem 
cells (69).  In Xenopus, Notch exerts inhibitory effects on cardiac differentiation (70).  In 
the hematopoietic stem cell (HSC) niche, inductive Notch signaling between HSC and 
osteoblasts maintains the HSCs in an undifferentiated state (71).  The differential 
response of various stem cells to Notch activation underscores the need to characterize 
the stem cell- specific responses which can be modulated under pathological conditions.   
 
2.5 HYDROGELS FOR CARDIAC CELL THERAPY 
A healthy myocardium is a contractile tissue composed of cardiomyocytes, 
endothelial and smooth muscle cells.  Efficient pump function requires the interaction of 
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these cells with the extracellular matrix (ECM) which provides stimuli for growth of 
cardiac cells, differentiation and migration of stem/progenitor cells.  However, 
myocardial infarction damages this organized tissue with extensive cell death, loss of 
contractility and formation of stiff fibrotic scar.   A variety of biomaterials have been 
developed to address these changes that occur after MI.  For cardiac applications, 
biomaterials need to developed with i) mechanical properties similar to the myocardium, 
ii) incorporation of signals for growth, proliferation and differentiation, iii) controlled 
degradation into non-toxic metabolites, and iv) limited foreign-body reaction and host- 
inflammatory response.  By providing mechanical support to the infarcted heart, 
biomaterials can increase wall thickness and decrease adverse remodeling after MI.   
When the mechanical properties of the biomaterial are similar to the myocardium, 
more pronounced effects have been observed.  For example, an injectable alginate 
hydrogel has been shown to increase myocardial mass and decreased end diastolic 
volume (72).  In a similar study, injection of a polyethylene glycol (PEG) hydrogel into 
infarcted rat hearts showed that the improvement in function seen at 4 weeks was lost at 3 
months suggesting that improvements in function by providing mechanical support can 
only provide temporary benefits (73).  For sustained improvement in cardiac function, 
injection of biomaterials with cells has been explored.  For cell delivery, the biomaterial 
should provide an environment for cell survival that does not interfere with integration 
and mechanical coupling to the host myocardium.   
2.5.1 Types of hydrogels 
Drug and cell delivery systems could be modulated to serve as instructive 
microenvironments in regenerative medicine.  Towards this end, several synthetic 
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biomaterials have been developed to mimic the natural extracellular matrix (ECM) for 
therapeutic use.  These include synthetic polymers, decellularized ECM, self assembling 
polymers and cell responsive hydrogels with varied applications.  Several biomaterials 
such as matrigel, PLGA, PEG, alginate and self-assembling peptides have been used as 
cell delivery vehicles to regenerate the myocardium. Advances in biomaterial design and 
fabrication processes have led to tunable hydrogels that can incorporate instructive cues, 
deliver cells/growth factors and regulate endogenous or implanted stem cell responses in 
the heart. 
Matrigel is a heterogenous mixture of soluble basement membrane proteins 
secreted by mouse tumor cells which polymerizes into a hydrogel at 37°C.  Embryonic 
stem cells injected in matrigel to the infarcted heart have shown improvement in function 
(74).  However, being obtained from mouse tumor makes these hydrogels unsuitable for 
clinical application.  Collagen is an abundant ECM protein present in the heart and other 
tissues.  Collagen production by fibroblasts is increased after infarction in the scar region.  
Being present in the heart makes collagen a nontoxic, non-immunogenic and 
biodegradable biomaterial. Collagen gels used to deliver MSCs to the pericardial space 
improves function and retention in pigs (75).  Tissue patches of collagen gels containing 
endothelial progenitor cells applied on the infarcted LV wall in rats results in improved 
cardiac function through increased vascular density (76).   
Fibrin is a protein that forms a FDA approved fibrin glue when fibrinogen is 
mixed with thrombin (77).  Application of fibrin glue containing MSCs as an epicardial 
patch on the heart improves function after MI through increased cell retention and 
angiogenesis (78).  It is also used as a vehicle to deliver proteins and plasmids through 
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catheters to the heart.  Decellularized extracellular matrix isolated from whole animal 
hearts can be milled into a powder and used as a hydrogel for cell therapy.  It has also 
been shown to promote cardiac gene expression in rat cardiac progenitor cells in vitro 
(79).  Poly Lactic acid-glycolic acid (PLGA) is a FDA-approved polymer used in tissue 
engineering scaffolds and microparticle formulations.  As the chemical formulation 
process could affect proteins and cells, it has been used as a substrate for microprinting 
defined geometries that promote stem cell differentiation.  For example, MSCs form 
elongated cell shape with myogenic gene expression on PLGA scaffolds with 20µm 
fibronectin strips (80).  PEG-based hydrogels have been used to deliver growth factors to 
the infarcted rat heart with improvements in function (81).  Apart from these hydrogels, 
microparticles such as polyketals and dendrimers have been used as siRNA delivery 
vehicles that have also resulted in improved cardiac function following MI in rodents (82, 
83).  The development of self-assembling peptide hydrogels has led to its use as a cell, 
drug and growth factor delivery vehicle for regenerative medicine applications as 
discussed below. 
 
2.5.2 Self-assembling peptide hydrogels 
Self-assembling peptides are composed of alternating hydrophilic (arginine or aspartic 
acid) and hydrophobic (alanine or lysine) amino acids with the peptide sequence H2N-
RARADADARARADADA-OH.  Due to the charges on the hydrophilic groups when the 
peptides are aligned, a stable antiparallel β-sheet is formed that at neutral pH polymerizes 
into a hydrogel (84).  The peptides self-assemble into nanofibers (7–20 nm in diameter) 
with >99% water content at physiological pH and osmolarity.  The peptide hydrogel has 
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been shown to be non-inflammatory and non-immunogenic (85, 86).  The peptide 
sequence does not contain any cell recognizable structures and is considered to be a non-
instructive hydrogel.  However, incorporation of the adhesion motif RGD (arginine– 
glycine–aspartic acid) in the self-assembling peptide improves survival of MSCs and 
promotes MSC differentiation into cardiomyocytes (87).  Furthermore, the 3D hydrogel 
environment also promotes attachment, proliferation and differentiation of different cell 
types: neuronal cells (88), endothelial cells (89), hepatocytes (90), chondrocytes (91), 
osteoblasts (92) and progenitor cells (54, 93).  During solid-phase synthesis, the peptides 
can be functionalized with ligands and adhesive motifs at the C-terminal to provide 
signaling cues that promote cell retention in the scaffold (85, 94).  The self assembling 
peptides can be functionalized with i) short motifs for cell adhesion to modulate human 
adipose stem cell behavior (95),  ii) VEGF to promote cardiac repair following infarction 
in pigs (86) and iii)  growth factors through biotin-streptavidin linkages for use in cell 
therapy (54).   
The hydrogels have also been used for cartilage repair, axon regeneration, 
treatment of bone defects and myocardial infarction (96).  In a pig model of MI, delivery 
of bone marrow mononuclear cells in a self-assembling peptide hydrogel improves 
retention, promotes vascular and endothelial differentiation and augments cardiac 
function 4 weeks after intramyocardial transplantation (97).  Furthermore, selective 
differentiation of stem cells can be achieved through incorporation of cell specific 
adhesion signals in the hydrogels. Inclusion of the neurite-promoting laminin epitope 
peptide (isoleucine-lysine-valine-alanine-valine) in the hydrogel directs differentiation of 
neural progenitors into neurons and not astrocytes (98, 99).  Work by Nickoloff et al., has 
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shown that a 20 amino acid long peptide mimicking the active site of the human Jagged1 
ligand, RJ can activate Notch1 signaling in keratinocytes (100).  RJ can be incorporated 
into self-assembling hydrogels with tunable mechanical properties to regulate Notch 
signaling and stem cell function.  After synthesis, the peptides can be purified by high 
pressure liquid chromatography on reverse-phase columns and the presence of a correct 






OXIDATIVE STRESS MEDIATED CARDIOGENIC GENE EXPRESSION IN 
MESENCHYMAL STEM CELLS 
 
3.1 INTRODUCTION 
Accumulating lines of evidence indicate beneficial effects of bone-marrow 
derived mesenchymal stem cells (MSCs) for treating MI in small and large animal studies 
(101).  Whereas MSCs are capable of differentiating into multiple lineages (102), upon 
delivery to the heart after acute MI, cardiogenic (all cell types in the myocardium) 
differentiation was noted (103).  Additionally, several studies have shown improvements 
in cardiac function following MI either by endogenous bone marrow (7) or by 
augmenting this endogenous MSC response via injection of GM-CSF and other stem cell 
mobilizing factors (40).  Finally, early human clinical trials have demonstrated modest, 
yet significant, improvements in cardiac performance after MSC administration (42, 
104).   
 Extensive published studies demonstrate significant increases in reactive oxygen 
species (ROS) almost immediately following an acute MI.  Elevated levels of ROS have 
deleterious effects on the cardiovascular system and are critical in the pathophysiology of 
heart failure.  Potential sources of ROS in the myocardium include the NADPH oxidases 
of fibroblasts and infiltrating inflammatory cells, as well as the myocytes themselves 
(105).  Ischemic injury further elevates ROS production in these cells which may 
influence differentiation of endogenous or implanted stem cells at the infarct site.  While 
effects of ROS on cardiac cell death, remodeling, and function are well studied, stem and 
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progenitor cells that could be used for potential regeneration have both adaptive and 
maladaptive responses to oxidative stress. For example, acute bursts of ROS to 
embryonic stem cells (ESCs) in culture facilitate differentiation toward the 
cardiomyocyte phenotype, while chronic exposure to H2O2 inhibits differentiation (106).  
Although the effect of ROS on certain stem cell types is fairly established, the exact 
signaling pathways regulated by ROS especially in the cardiogenic differentiation of stem 
cells is under intense investigation.  Thus, pinpointing the exact signals modulated by 
ROS leading to alterations in MSC differentiation is of great therapeutic interest.   
One of the major signaling pathways involved in stem cell differentiation is the 
Notch signaling pathway.  Notch signaling is an evolutionarily conserved intercellular 
communication pathway that regulates diverse cellular processes, ranging from cell fate 
decision, differentiation, and proliferation to apoptosis.  Activation of the Notch receptor 
by adjacent cell surface bound ligands of the Jagged and Delta family leads to proteolytic 
cleavage and nuclear translocation of the Notch intracellular domain (NICD) and 
subsequent transcriptional regulation of target genes, leading to maintenance of cells in 
an uncommitted state or induction of cell-type specific differentiation (107).  Notch 
signaling promotes early cardiac development (64) and has also been identified to 
precede heart regeneration in zebrafish (17).  Furthermore, certain mutations in Notch 
ligands or receptors are associated with embryonic lethality in mice (14).   Apart from 
regulating normal development and damage-induced repair, Notch signaling has also 
been found to promote cardiomyocyte survival (67).  Notch activation has been shown to 
promote cardiac gene expression in circulating endothelial progenitor cells (68),  bone 
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marrow-derived MSCs (11) and cardiac progenitors (10) while  attenuating cardiac 
differentiation of embryonic stem cells (69).  
While, the effects of Notch signaling on different cell types are well studied, its 
regulation by oxidative stress is unknown. We therefore sought to determine the role of 
oxidative stress on cardiogenic gene expression in MSCs and whether Notch signaling 
plays a role in directing differentiation of MSCs in the setting of elevated local H2O2 
levels following MI.  Our data suggest that H2O2 or glucose oxidase mediated oxidative 
stress promotes cardiogenic differentiation in adult stem/progenitor cells through 
upregulation of Notch1 signaling, possibly involving Wnt11. 
 
3.2 RESULTS 
Mesenchymal stem cell characterization 
Mesenchymal stem cells (MSCs) had a spindle shaped, fibroblast-like 
morphology and expressed common mesenchymal cell surface markers, c-Kit, CD73, 
CD90 and CD105, with low expression of the hematopoietic marker CD45 and no 
expression of CD34 (Figure 3.1A).  To determine the multipotent trilineage 
differentiation capacity, the MSCs were cultured for 21 days in media that promotes 
differentiation into adipogenic, osteogenic and chondrogenic lineages.  As shown in 
Figure 3.1B, the MSCs differentiated into the three lineages as demonstrated by staining 
for Oil Red O, Alizarin Red and Toluidine blue respectively.  Moreover, treatment with 
100µM H2O2 for 1 week did not induce trilineage differentiation indicating that the 
MSCs are multipotent but H2O2 treatment does not promote differentiation into 




Figure 3.1. Characterization of Mesenchymal stem cells.  (A) The MSCs isolated from 
rat bone marrow were culture expanded and % +ve cells expressing c-Kit, CD34, CD45, 
CD73, CD90 and CD105 was determined by flow analysis. (B) The trilineage 
differentiation potential of the mesenchymal stem cells (MSCs) cultured on adipogenic, 
osteogenic and chondrogenic media or ±100 µM H2O2 was assessed by Oil Red O, 






Oxidative stress regulates early cardiogenic gene expression in MSCs 
To determine whether H2O2 or Glucose oxidase (GOX)-mediated oxidative stress 
regulates endothelial gene expression, bone marrow-derived MSCs were cultured in 
media containing hydrogen peroxide (H2O2; 0-100µM) for 1 week or Glucose oxidase 
(GOX; 0-5 mU/ml) for 48hrs.  The mRNA expression of VEGF receptor Flt1, vWF, and 
PECAM1 following exposure to H2O2 or GOX was quantified by qRT-PCR.  While there 
was no effect due to lower levels of H2O2 (0.1-10µM), high levels (100µM) significantly 
increased the expression of Flt1 by 2-fold (p<0.05, Figure 3.2A), vWF by almost 2-fold 
(p<0.05, Figure 3.2B) and PECAM1 by 3-fold (p<0.01, Figure 3.2C).  In MSCs treated 
with GOX for 48 hrs, no change in gene expression was seen at the lower doses (0.01-2.5 
mU/ml).  However at 5mU/ml, a significant increase in expression of Flt1 by 400- fold 
(p<0.05, Figure 3.2D), vWF by 150- fold (p<0.05, Figure 3.2E) and PECAM1 by 20- 








Figure 3.2. Oxidative stress promotes endothelial gene expression in MSCs.  MSCs 
were treated with either H2O2 for 1 week (0-100µM; A-C) or GOX for 48h (0-5mU/ml; 
D-F).  Expression of the endothelial markers Flt1 (A,D), vWF (B,E) and PECAM1 (C,F)  
was determined by qRT-PCR. Values are mean ± SEM after normalizing gene expression 
to GAPDH (A-C) or 18S (D-F) expression. For A-C, n≥4 and D-F, n≥6 . * p<0.05 and ** 
p<0.01 when compared to control (0µM H2O2 or 0mU/ml GOX) by one-way ANOVA 
followed by Dunnett’s post test. 
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To determine whether H2O2 or GOX-mediated oxidative stress regulates cardiac 
gene expression, we measured levels of early cardiac markers nkx2-5 and α-myosin 
heavy chain (αMHC). While treatment of MSCs with low levels of H2O2 (0.1-10µM) had 
no effect on αMHC levels, treatment with 100µM H2O2 significantly increased 
expression by 2-fold (p<0.05, Figure 3.3A) compared with time-matched, untreated 
controls.  To confirm with another early cardiac marker, nkx2-5 gene expression was 
measured.  As shown in Figure 3.3B, the expression of nkx2-5 increased by nearly 2-fold 
(p<0.05) in 100µM H2O2 treated MSCs.  In MSCs treated with GOX for 48 hrs, no 
change in gene expression was seen at the lower doses (0.01-2.5 mU/ml).  In MSCs 
treated with 5mU/ml GOX, a 30- fold increase in expression of αMHC (p<0.001, Figure 





Figure 3.3. Oxidative stress regulates cardiac gene expression in MSCs.  MSCs were 
treated with either H2O2for 1 week (0-100µM; A,B) or GOX for 48h (0-5mU/ml; C,D).  
Expression of the cardiac markers αMHC (A,C) and nkx2-5 (B,D) was determined by 
qRT-PCR. Values are mean ± SEM after normalizing gene expression to GAPDH (A,B) 
or 18S (C,D) expression. For A and B, n≥4; C and D, n≥5. * p<0.05 and *** p<0.001 
when compared to control (0µM H2O2 or 0mU/ml GOX) by one-way ANOVA followed 
by Dunnett’s post test.   
 
To identify whether H2O2 regulated expression of smooth muscle markers, the 
levels of the early smooth muscle markers-smooth muscle α-actin (sm α-actin) and the 
calponin-related protein sm22α were examined. Treatment with 100µM H2O2 
significantly decreased expression of smα-actin by 3-fold (p<0.01, Figure3.4A) and 
sm22α expression by 2-fold (p<0.01, Figure 3.4B). Similarly, the expression of vimentin, 
an intermediate filament protein characteristic of fibroblasts, was significantly decreased 
by 1.5-fold in both 1µM (p<0.05) and 100µM H2O2-treated MSCs (p<0.01) as shown in 
Figure 3.4C.  No change in expression of sm α-actin, sm22α, and vimentin was observed 











Figure 3.4. Oxidative stress differentially modulates smooth muscle and fibroblast 
gene expression in MSCs.  MSCs were treated with either H2O2 for 1 week (0-100µM; 
A-C) or GOX for 48h (0-5mU/ml; D-F).  Expression of the smooth muscle markers sm α-
actin (A,D), sm22α (B,E) and the fibroblast marker Vimentin (C,F) was determined by 
qRT-PCR. Values are mean ± SEM after normalizing gene expression to GAPDH 
expression.  For A-C,n≥3; and D-F, n=6. * p<0.05 and ** p<0.01 when compared to 
control (0µM H2O2or 0mU/ml GOX) by one-way ANOVA followed by Dunnett’s post 
test.  
To verify if the changes in cardiogenic gene expression translated to changes in 
protein expression, levels of the cardiac marker α-MHC, endothelial marker Flt1and 
smooth muscle α-actin were determined by flow analysis (Figure 3.5A).  As shown in 
the grouped data in Figure 3.5B, GOX induced  a 4-fold increase in cardiac α-MHC 
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expressing cells (left; p<0.05), a 1.4-fold change in Flt1 expressing cells (middle; 
p=0.07), and a 1.5- fold decrease in sm α-actin expressing cells (right; p<0.05). 
 
Figure 3.5. Quantification of GOX-mediated cardiogenic protein expression in 
MSCs.  MSCs were treated with GOX (5mU/ml) for 48h.  Expression of the cardiac 
proteins (αMHC, Flt1 and sm α-actin) was determined by flow cytometry (A) and 
quantified in B (mean±SEM with n≥3. * p<0.05 vs control by Student’s paired t-test). 
Oxidative stress induces Notch1 signaling  
As the Notch signaling pathway has been shown to be critical for cardiovascular 
development and differentiation, we analyzed the expression levels of the cell surface 
receptor Notch1 and its ligand Jagged1 in H2O2 and GOX treated MSCs.  High levels of 
H2O2 (100µM) augmented Notch1 gene expression by1.5-fold after 1week and 
significantly increased Notch intracellular domain (NICD) cleavage (p<0.05 for gene, 
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p<0.01 for NICD cleavage, Figure 3.6 A&B), while decreasing Jagged1 expression by 
about 1.5-fold (p<0.05, Figure 3.6F).  Moreover, the expression of the downstream 
targets of Notch1, Hes5 was increased by up-to 2-fold in MSCs treated with 100µM of 
H2O2 (p<0.05, Figure 3.6D) and Hey1 by 1.5 fold (p<0.01, Figure 3.6E).While no 
change in gene expression was observed in MSCs treated with 0-2.5mU/ml GOX, a 
significant increase in expression of Notch1 (15-fold, p<0.05, Figure 3.6C), Hes5 (150-
fold, p<0.05, Figure 3.6G), Hey1 (150-fold, p<0.01, Figure 3.6H) and a significant 
decrease in expression of Jag1 (p<0.05, Figure 3.6I) was observed in MSCs treated with 




Figure 3.6. Oxidative stress increases expression of Notch1 and its downstream 
targets.  MSCs were treated with either H2O2 for 1 week (0-100µM; A,B,D-F) or GOX 
for 48h (0-5mU/ml; C,G-I).  The mRNA expression levels of Notch1 (A,C), Hes5 (D,G), 
Hey1 (E,H) and the ligand Jagged1 (F,I) was determined by qRT-PCR.  (B) 
Quantification of expression of activated Notch1 (NICD) with representative Western 
blot image.  Values are mean±SEM after normalizing gene expression and Western blots 
to GAPDH (A,B,D-F) or 18S (C,G-I) expression and protein, respectively. For A,B,D-
F,n≥4; C,G-I,n≥6; * p<0.05 and ** p<0.01 when compared to control (0µM H2O2 or 
0mU/ml GOX) by one-way ANOVA followed by Dunnett’s post test and Student’s 
unpaired t-test for B. 
To determine the Notch1 related genes that were regulated in MSCs treated with 
5mU/ml of GOX, a PCR array was performed.  The data was analyzed and grouped 
based on known associated function of the gene.  As shown in Figure 3.7A, treatment of 
MSCs with 5mU/ml of GOX resulted in an increase in expression of i) Wnt11(5-fold) 
and its receptor Fzd3 (3-fold), ii) genes involved in cell adhesion and proliferation (Cd44, 
Ccnd1, Cflar; ~3fold), iii) ligands for Notch1 (Dll1, Dll4; 3-5fold), iv) components of γ-
secretase complex involved in Notch1 processing (Psen1, Mfng, Lfng, hr, Neurl; 3-15 
fold) and iv) downstream target of Notch1 (Hes5; 5-fold).  As Wnt11 is a known 
downstream target of Notch1, the expression of Wnt11 was validated in MSCs treated 
with GOX (0 or 5mU/ml).  As shown in Figure 3.7B, a significant increase in Wnt11 
expression was observed in MSCs treated with 5mU/ml GOX.  The results were also 
validated using cardiac progenitor cells where a similar significant increase was observed 




Figure 3.7. PCR array analysis of Notch1 related genes.  Gene expression of Notch1 
related genes in MSCs treated with GOX (0 or 5mU/ml) was analyzed using a PCR array. 
(A) Fold increase in gene expression in 5mU/ml GOX treated MSCs over control cells 
was normalized to β-actin.  (B) Validation of increase in Wnt11 expression upon 5mU/ml 
GOX treatment in MSCs (top, p<0.05) and CPCs (bottom, p=0.08). 
 To determine if the effects of oxidative stress mediated by H2O2 are specific for 
MSCs, we subjected adult cardiac progenitor cells to GOX treatment.  Interestingly, an 
increase in expression of Notch1 by 15-fold (p<0.001) and Hes5 by 175- fold (p<0.05) 
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along with changes in cardiogenic gene expression similar to the response of MSCs was 
observed (Figure 3.8). 
 
 
Figure 3.8. Oxidative stress regulates cardiogenic gene expression in cardiac 
progenitor cells.  Cardiogenic gene expression in cardiac progenitor cells treated with 
GOX (0 or 5mU/ml) was determined by qRT-PCR.  An increase in expression of Notch1 
(p<0.001), Hes5 (p<0.05), flt1 (p=0.08), vWF (p<0.05), nkx2-5 (p<0.01), sm22α 
(p<0.05) was observed. Values are mean±SEM after normalizing gene expression to 18S 
expression (n=3, *p<0.05, **p<0.01, ***p<0.001 compared to control (0mU/ml GOX) 
by Student’s unpaired t-test). 
Oxidative stress regulates cardiogenic gene expression through Notch1 
To determine the link between increased Notch1 gene expression and activity by 
H2O2 treatment and cardiogenic gene regulation, MSCs were treated with a γ-secretase 
inhibitor IX DAPT (10µM) for 1 week with or without 100µM H2O2. γ-secretase is 
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required for the release of the active Notch1 intracellular domain (NICD) (58) and thus 
its inhibition blocks Notch1 activation. To demonstrate that DAPT inhibits Notch1 
activation, MSCs were treated with DAPT (10µM) for 1 week with or without 100µM 
H2O2 and protein levels of NICD were measured by Western blotting.    Knockdown of 
Notch1 expression using siRNA was also attempted.  MSCs were transfected with siRNA 
using oligofectamine as it resulted in the highest transfection efficiency when compared 
to other commercially available reagents (Figure 3.9A).  As shown in Figure 3.9B, 
siNotch1 significantly decreased mRNA expression of Notch1 (p<0.05) when compared 
to untreated or siNC treated MSCs.  Furthermore, siNotch1 decreased the GOX induced 
increase in Notch1 expression comparable to untreated cells while the siNC had no effect 
(Figure 3.9C).  As shown in Figure 3.9D, DAPT decreases NICD expression in presence 









Figure 3.9. Notch1 knockdown using siRNA and DAPT.  (A) MSCs were transfected  
with mock siRNA labeled with Cy3 for 24h and transfection efficiency of commercially 
available reagents Oligofectamine, HiPerfect and Lipofectamine RNAimax was 
evaluated.  Oligofectamine with the highest transfection efficiency was chosen for all 
siRNA studies.  (B) MSCs were transfected with negative control siRNA (siNC) or 
siNotch1 for 48h.  The mRNA expression of Notch1 is significantly decreased with 
siNotch1 transfection when compared to transfection reagent or siNC treated MSCs. (C) 
MSCs were transfected with 25nM of negative control siRNA (siNC) or siNotch1 for 48h 
in presence of 5mU/ml GOX.  The increase in protein levels of the Notch1 Intracellular 
A         B 











Domain (NICD) by GOX are decreased by addition of siNotch1 while levels are 
unaltered by siNC.  (D) Representative Western blot for NICD (upper) and GAPDH 
(lower) in MSCs treated with vehicle, 100µM H2O2, or 100µM H2O2 + 10µM DAPT 
respectively (mean±SEM,  * p<0.05, n≥5 by One-way ANOVA followed by Dunnett’s 
post test).   
 
Figure 3.10. H2O2 does not alter mRNA expression of ADAMs 10 and 17.  MSCs 
were treated with 100µM H2O2 for 1 week and mRNA expression of (A) ADAM10 and 
(B) ADAM17 was measured by real time qPCR (mean±SEM,  n=10 by Student’s 
unpaired t-test). 
ADAM10 and ADAM17 are mettaloproteases are involved in Notch1 processing, 
Treatment with H2O2 did not affect the expression or activity of ADAM17 (Figure 3.10 
A and B).  Inhibition of Notch1 signaling by DAPT for 1 week had a small but non-
significant decrease on basal αMHC expression, but prevented the increase seen in 
100µM H2O2 treated cells (p<0.05 vs. H2O2 alone; Figure 3.11A).  A similar effect of 
DAPT was observed in the expression pattern of the endothelial marker Flt1, where 
Notch1 inhibition prevented the increase in Flt1 expression by 100µM H2O2 (p<0.05vs 
A      B 
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H2O2 alone, Figure 3.11B). Interestingly, inhibition of basal Notch1 signaling by DAPT 
decreased expression of sm α-actin by 4-fold (p<0.001, Figure 3.11C) and sm22α by 3-
fold (p<0.001, Figure 3.11D).  This decrease was further augmented by the combined 
treatment with 100µM H2O2 and DAPT with a 10-fold and 6-fold decrease in expression 
of smooth muscle α-actin and sm22α, respectively (p<0.001vs H2O2 alone, Figures 
3.11C and D). 
To determine if glucose oxidase mediated changes in cardiogenic gene expression 
through Notch1 signaling, MSCs were treated with 5mU/ml GOX in presence of a 
negative control siRNA (siNC) or siNotch1 for 48h.  As shown in Figures 3.11E-H, 
addition of siNotch1 did not clearly demonstrate dependence of GOX-mediated gene 
expression changes on Notch1. 
 
Figure 3.11. Oxidative stress regulates cardiogenic gene expression in MSCs 
through Notch1 dependent and independent manner.  MSCs were treated with 
100µM H2O2 ± Notch1 inhibitor DAPT (A-D) or with 5mU/ml GOX± siNotch1 (E-
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H).Expression of the cardiac marker αMHC (A,E), endothelial marker Flt1 (B,F), and the 
smooth muscle markers sm α-actin (C,G) and sm22α (D,H) were determined by qRT-
PCR. Values are mean±SEM after normalizing gene expression to GAPDH (A-D) or 18S 
(E-H) expression. n≥4, *p<0.05 and **p<0.01 compared to control (0µM H2O2), or 
#p<0.05 compared to 100µM H2O2 by one-way ANOVA followed by Bonferroni’s post 
test.   
 
3.3 DISCUSSION 
Previous studies have shown that transplantation of MSCs in the heart following 
MI leads to small but significant functional improvements (7).  Understanding the 
molecular mechanisms by which MSCs promote cardiac function, especially in the 
oxidative microenvironment following MI will greatly aid in improving efficacy of stem 
cell-based therapies.  Following myocardial infarction, elevated levels of reactive oxygen 
species (ROS) have been found at the infarct site (106) suggesting that ROS such as H2O2 
might influence the differentiation and function of implanted MSCs.  As substantial 
amounts of ROS have been found in the area at risk after MI (29), and as ROS have been 
identified to play a critical role in the differentiation of other stem cell types (108, 109), 
we chose to study the effect of H2O2 on MSC differentiation in vitro.  Here we show that 
MSCs that were subjected to pulses of pathophysiological levels of H2O2 for 1 week or 
continuous H2O2 produced by oxidation of glucose in the extracellular media by Glucose 
oxidase (GOX) for 48h increased the expression of early cardiac- and endothelial- genes 
with decreased expression of early smooth muscle genes.   
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Although only a 2-fold increase in cardiac markers is observed with H2O2 
treatment, addition of GOX results in a more robust increase of 30-fold for α-MHC and 
75-fold for nkx2-5 which are comparable to neonatal rat ventricular cardiomyocytes with 
40- fold and 100- fold higher expression of α-MHC and nkx2-5 respectively when 
compared to untreated MSCs.  These results were in agreement with those reported for 
human embryonic stem cells (ESCs) (109).  Similar results were obtained when adult 
heart resident cardiac progenitor cells (CPCs) were treated with GOX.  These data 
demonstrate redox-sensitive alteration in cardiogenic gene expression in MSCs and 
CPCs. 
Our results also demonstrate that only high levels of exogenous H2O2 (100µM) 
and high concentrations of GOX (5mU/ml) were able to regulate expression of Notch1 
and cardiogenic genes.  We believe this very narrow threshold effect may be due to a 
combination of factors such as presence of basal H2O2 and constitutive expression of 
antioxidant enzymes by cells.  Unpublished data from our laboratory demonstrate basal 
H2O2 levels of 1µM in cultured stem cells as measured by electron paramagnetic spin 
resonance.  Recent reports demonstrate many stem cells including MSCs contain higher 
levels of antioxidants (110, 111).  We measured H2O2 levels in stem cells following 
addition of 100µM H2O2 and found that the concentration reduced to 12µM, within an 
hour, indicating rapid scavenging of exogenous oxidants.  Finally, recent data from 
human MSCs determined higher levels of catalase and glutathione peroxidase, with no 
changes in superoxide dismutase compared with other stem cells and fully differentiated 
cells (111).  In that study, there was a threshold response with human MSCs 
demonstrating almost 80% survival at 4mM H2O2, falling to <10% at 8mM.  Our studies 
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indicate robust survival at 100µM H2O2 and 5mU/ml GOX with cellular responses, but 
higher concentrations to be potentially cytotoxic.  Taken together, these data demonstrate 
that many cells, especially stem and progenitor, have threshold responses with small 
windows of dose-responses. 
Next, we investigated whether H2O2 regulates any signaling pathway involved in 
stem cell differentiation. One of the signaling pathways that greatly influences stem cell 
differentiation is the Notch signaling pathway (112). Therefore, we investigated whether 
interplay existed between H2O2 and Notch1 signaling pathways.  Interestingly, mRNA 
level of Notch1 as well as proteolytic cleavage of the Notch1 intracellular domain 
(NICD) was upregulated by treatment with either 100µM H2O2or GOX suggesting that 
high levels of H2O2 affect expression of both the mRNA and protein activity of Notch1.  
Although only a 1.5-fold increase in mRNA and 2-fold increase in NICD protein is 
observed, reports suggest that very small changes in Notch1 activation are sufficient to 
induce Notch1 signaling (107).  Furthermore, this increase in Notch1 also significantly 
increased mRNA expression of downstream targets of Notch1.  As MSCs were pulsed 
with H2O2for 1 week, discontinuous oxidative stress resulted in small fold changes in 
cardiac gene expression.  While these changes may not represent true differentiation, it 
suggests that H2O2 levels influence cardiac gene expression in MSCs.   
Although upregulation of cardiac and endothelial genes by Notch1 signaling may 
appear to be counterintuitive given the role of Notch signaling in suppressing 
cardiomyogenesis in ESCs (69), upregulation of nkx2-5 and vWF is consistent with 
reports indicating involvement of Notch1 signaling in regulating these genes in cardiac 
progenitor cells and bone marrow stromal cells respectively (10, 113).  Our observation 
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that treatment with 100µM H2O2or 5mU/ml GOX decreased expression of the Notch1 
ligand Jagged1 in MSCs is consistent with previous reports of an inverse relationship 
between expression levels of Notch1 and Jagged 1 in other cell types (114).  As we 
observed changes in cardiogenic gene expression at the mRNA level, we sought to 
determine if these changes translated correspondingly at the protein level.  Flow analysis 
of GOX-treated MSCs indicated that a small number of MSCs have high expression of α-
MHC along with increase in Flt1 expression and decreased sm α-actin expression.  These 
results suggest that GOX treatment increases the frequency α-MHC and Flt1 positive 
cells while decreasing sm α-actin+ cells. 
The mechanism of upregulation of Notch1 activation by H2O2may be due to 
activation of enzymes involved in Notch1 cleavage and processing.  It is possible that 
H2O2may increase Notch1 activation via γ-secretase activation as H2O2 mediated increase 
in γ-secretase activation has been demonstrated in the pathogenesis of Alzheimer’s 
disease (115).  Pharmacological inhibition of γ-secretase activity using DAPT inhibits 
Notch1 activation in different stem cells (113, 116).  Therefore, to determine whether 
H2O2 regulates cardiogenic gene expression in MSCs through Notch1 signaling, we 
blocked Notch1 activation daily using DAPT and analyzed expression of the different 
cardiogenic markers in presence and absence of 100µM H2O2.   Among the markers 
analyzed, the increase in expression of the high affinity VEGF receptor Flt1 and the 
cardiac marker α-MHC observed with 100µM H2O2 was abrogated by co-treatment with 
DAPT indicating that H2O2 regulates Flt1 and α-MHC expression through Notch1 
signaling.  We attempted knockdown of Notch1 using siRNA, however, this was not 
successful as siRNAs that significantly reduced Notch1 gene expression greatly reduced 
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cell survival over the 1 week of treatment.  To determine if Glucose oxidase (GOX) 
mediated acute changes in cardiogenic gene expression through Notch1 signaling, MSCs 
were transfected with siNotch1 along with GOX.  Treatment with siNotch1 showed a 
strong trend towards decreasing the GOX-mediated increase in α-MHC and Flt1 while no 
effect was observed on smooth muscle gene expression by addition of GOX ± siNotch1.  
The lack of changes in ADAM 10/17 expression on H2O2-treatment suggests the 
importance of the γ-secretase component of this pathway.  Furthermore, treatment with 
GOX increased expression of enzymes involved in processing of Notch1 and Jagged1 
such as Mfng, Lfng and Neurl indicating that H2O2 influences both notch1 cleavage and 
processing enzymes. 
Expression of smooth muscle markers decreased significantly upon treatment 
with 100µM H2O2.  Inhibition of Notch1 also decreased basal expression of smooth 
muscle markers, keeping with prior findings (117).  Interestingly, co-treatment of MSCs 
with H2O2 and DAPT resulted in a further decrease in smooth muscle markers.  This 
indicates that H2O2 decreases smooth muscle gene expression through a parallel pathway, 
and that activation of Notch serves as a compensatory mechanism to stabilize smooth 
muscle gene expression.  Finally, expression of vimentin was also decreased by both 
H2O2 and GOX treatment.  While vimentin is expressed in many cell types, it is most 
prevalent in fibroblasts and thought to be a partial marker of fibroblastic lineage (118) 
and lower expression could lead to decreased fibrosis. 
To understand the mechanism by which oxidative stress mediated by GOX 
resulted in robust increases in cardiogenic gene expression, the expression of Notch1-
related genes in GOX treated MSCs was analyzed by PCR array.  Interestingly, Wnt11 
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expression was increased in GOX treated MSCs.  Wnt11 signaling has been shown to 
promote cardiomyogenic differentiation of human endothelial progenitor cells and mouse 
marrow mononuclear cells (119, 120).  Moreover, Wnt signaling has been identified as a 
downstream target of Notch1 that regulates expression of cardiac transcription factors 
during mouse cardiogenesis and is essential for cardiac development (121, 122).  MSCs 
overexpressing Wnt11 have been shown to be cardioprotective following oxidative stress 




Figure 3.12. Proposed model of H2O2/GOX mediated induction of cardiogenic gene 
expression in MSCs. 
 
Of note, MSCs used in this study were a heterogenous mix of cells present in the 
adult rat bone marrow.  It is unclear whether there is one particular lineage in the 
heterogenous mix that is most responsible for these changes or whether Notch1 is 
activated in all these cell types.  Though published literature suggests that all these cells 
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express Notch (10, 71), the optimal cell type needs to be determined.   To our knowledge, 
this study demonstrates for the first time two important findings in the field of stem cell 
therapy.  Oxidative stress in rat bone marrow derived MSCs and heart derived CPCs i) 
regulates expression of selected cardiac, endothelial, and smooth muscle genes and ii) 
promotes Notch1 signaling and downstream Wnt11 activation.  Our current working 
model is depicted in Figure 3.12 and summarizes the findings of our study.  Given that 
cardiogenic gene expression of 2 adult progenitor types (MSCs and CPCs) was induced 
by high levels of H2O2/GOX via Notch1 signaling, this may represent an important 
conserved response.  As both of these cell types are in clinical trials, this study may have 





HYDROGEL-DEPENDENT NOTCH1 ACTIVATION MODULATES  
CARDIAC PROGENITOR CELL FUNCTION 
 
4.1 INTRODUCTION 
Heart failure is the leading cause of death worldwide and myocardial infarction 
(MI) is the predominant cause (1).  While heart transplantation is the most viable 
treatment, limited availability of donor hearts, complications from immunosuppression, 
and possibility of graft failure have necessitated the search for treatment alternatives.  
New emphasis has been placed on tissue engineering approaches to treat MI including 
delivery of growth factors and/or stem cells via direct injection, with natural scaffolds 
such as gelatin and alginate or with artificial self-assembling peptide scaffolds (125, 126).  
Evidence for myocyte renewal in human hearts and the existence of cardiac progenitor 
cells (CPCs) in niches in the post natal heart have consequently led to cell-based 
therapeutic strategies (31, 127).  These cells have been identified based on expression of 
cell surface markers (c-Kit, Sca1), ability to efflux dyes, or form spheroids in culture.  
Success in clinical trials based on CPC therapy for cardiovascular diseases (15, 16) and 
the inherent ability of CPCs to differentiate into cardiovascular cell types (31) has 
established CPCs as a clinically relevant cell source for cardiac therapy.   
However, the reparative capacity of different CPCs is dependent on the 
myocardial environment, activation of specific signaling pathways, and sustained 
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retention in the infarcted heart.  While VEGF, IGF-1 and Notch signaling promote CPC 
mediated cardiac repair, Wnt activation exerts anti-proliferative effects (10, 128-130).   
Studies have demonstrated the effect of incorporating such signals into natural or 
synthetic scaffolds to promote cardiac regeneration (54, 81).  Injectable self-assembling 
peptide (SAP) hydrogels are composed of 16 amino acid long peptides that assemble into 
3D microenvironments under physiological conditions (85).  SAP hydrogels have been 
used for delivery of growth factors and stem cells in vivo and as a 3D system to study 
stem cell/biomaterial interactions and direct stem cell responses. Self-assembling 
peptides (SAP) promote cell-cell interactions (85) that are essential for progenitor cell 
survival and differentiation in the hydrogel.  Studies have demonstrated the effect of 
incorporating growth factors and other bioactive signals in the hydrogel on improving 
stem/progenitor cell function in the infarcted heart upon transplantation.  For example, 
SAPs functionalized with homing and adhesion motifs have been shown to regulate 
human adipose stem cell behavior in vitro (95).  Delivery of VEGF in the SAPs has also 
been shown to improve cardiac function following infarction in rats and pigs through 
increased angiogenesis (86).  The SAP used in this study (RARADADA)2 has hydrophilic 
and hydrophobic residues with alternating charges that allows for self-assembly into a 
hydrogel under physiologic pH and osmolarity.  Along with providing a 3D environment 
for stem cells, these hydrogels can also be precisely modified with bioactive motifs to 
deliver cues for regeneration.  This is important as stem cells require spatially and 
temporally defined signals to exert their beneficial effects.  
Notch signaling is an evolutionarily conserved cell-cell communication pathway 
where the binding of the ligand Jagged1 on the signal sending cell to the Notch1 receptor 
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on the signal receiving cell activates downstream signaling events that regulates gene 
expression in several cell types (58).  Deletion of Notch, the ligands or the downstream 
effectors is embryonic lethal due to cardiovascular defects suggesting the importance of 
Notch signaling in early cardiac development (131).  Further, Notch signaling has been 
shown to precede cardiac regeneration in zebrafish (17).   Mechanistically, the external 
force generated by ligand endocytosis on binding to the Notch1 receptor is required for 
Notch1 activation in the signal receiving cell (132).  To achieve this force generation, we 
immobilized a peptide mimic of the Notch1 ligand Jagged1 (RJ) in the 3D hydrogel.  The 
peptide RJ used in this study has been shown to promotes differentiation of keratinocyte 
and monocyte derived dendritic cells by activating Notch1 signaling (100, 133).  
However, the effect of activating Notch1 signaling using a peptide mimic of Jagged1 in 
progenitor cells for cardiac regeneration has not been investigated.  Therefore, we 
designed a SAP hydrogel that incorporated the Jagged1 peptide RJ to enhance cardiac 
differentiation of CPCs.  We then investigated the effect of Notch1 activation on 
cardiogenic gene expression, growth factor production and cardiac repair through in vitro 





Mechanical testing of Young’s modulus of the different hydrogels using atomic 
force microscopy showed that addition of either the scrambled or RJ peptide to the SAP 
did not change the Young’s modulus in comparison with the unmodified hydrogels at 
both 1 and 2% w/v.  The average Young’s modulus of all the 1% and 2% hydrogels was 
500Pa and 1800Pa respectively (Fig. 4.1A).  Evaluation of hydrogel swelling ratio 
demonstrated that the 1% hydrogels had a significantly higher swelling ratio than the 
corresponding 2% hydrogels indicating a more loosely linked peptide network at lower 
stiffness (n=3, p<0.05, Fig. 4.1B).  There was no significant effect of addition of either 
scrambled (RS) or RJ peptide.   
 
Figure 4.1:  Mechanical characterization of the hydrogels. (A) Atomic Force 
Microscopy measurements of the Young’s modulus of the hydrogels.  The average 
Young’s modulus of the 1% hydrogels (1R, 1RS and 1RJ) is 500Pa and the 2% hydrogels 
(2R, 2RS, 2RJ) is 1800Pa. *** p<0.001, Student’s t-test.  (B) Swelling ratio of the 
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hydrogels determined at 24h following gellation.  All the 1% hydrogels had a 
significantly higher swelling ratio than the corresponding 2% hydrogels indicating a more 
loosely cross-linked network. n=3, * p<0.05, Student’s t-test. 
RJ-mediated Notch1 activation is stiffness dependent 
CHO cells with Notch1-responsive YFP expression were cultured in 96 well 
plates with media containing 20 or 40µM of R, RS or RJ for 48h.   
  
Figure 4.2:  Notch1 activation in 3D is stiffness dependent.  (A) CHO cells with 
Notch1 responsive YFP expression were cultured in 2D with media containing the 
peptides (R, RS and RJ) at 20 and 40µM for 48h.  A significant increase in Notch1 
activation was observed on treatment with 40µM RJ, n=3, * p<0.05, one-way ANOVA. 
(B) CHO cells were cultured in 3D in 1-3% w/v hydrogels containing R, RS or RJ for 
48h.  A significant increase in Notch1 activation was observed on increasing % hydrogel 
(open bars) and presence of RJ at 2% had the highest levels of Notch1 activation (middle 
black bar), n=7, * p<0.05, two-way ANOVA. 
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A significant increase in YFP expression was observed on treatment with RJ at 40 
µM compared to all other treatment groups (p<0.05, n=3, Fig. 4.2A).  These cells were 
also cultured in 3D in 1, 2 or 3% w/v hydrogels composed of R, RS or RJ for 48h. A 
significant increase in YFP expression was observed with increasing hydrogel stiffness in 
the absence of any ligand (n=7, p<0.01, open bars, Fig. 4.2B).  Interestingly, the presence 
of RJ in 2% hydrogels resulted in maximum Notch1 activation (p<0.05, black bar, Fig. 
2B).  Further increase in stiffness to 3% w/v did not promote Notch1 activation.  
Stiffness dependent Notch1 activation differentially regulates CPC gene expression  
CPCs were clonally expanded and characterized as described in (79).  Flow analysis 
demonstrated >96% expression of the Notch1 receptor on CPCs, >90% expression of the 




Figure 4.3: Characterization of CPCs.  Representative histogram of cell surface 
expression of c-Kit, nkx2-5, gata4 and Notch1 on CPCs. 
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For in vitro studies, CPCs were embedded in 1 or 2% (w/v) SAP hydrogels (1R, 
1RS, 1RJ or 2R, 2RS, 2RJ) and cultured for 48h.  Culture in 1% hydrogels with RJ 
resulted in a significant increase in Hey1, a downstream target of Notch1 signaling 
(p<0.05, n=4; Fig. 4.4A).  A significant increase in expression of the endothelial genes 
Flt1 (p<0.05, n=5) and vWF (p<0.05, n=9; Fig. 4.4B and C), and smooth muscle genes 
sm22α (p<0.05, n=7) and sm α-actin (p<0.05, n=7; Fig. 4.4D and E).  No change in 
expression of cardiac genes, nkx2-5, MEF2C and GATA4 was observed (n=4, Fig. 4.4 F- 
H). 
 
Figure 4.4:  Culture of CPCs in 1% hydrogels with RJ activates Notch1 signaling 
and promotes endothelial and smooth muscle gene expression.  CPCs were cultured in 
1% hydrogels (R, RS, RJ) for 48h and expression of (A) Notch1 downstream target, 
F         G                    H 
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Hey1, (B) VEGF receptor1 Flt1, (C) vWF, (D) sm22α, (E) sm α-actin, (F) nkx2-5, (G) 
MEF2C, and (H) GATA4 was measured by qPCR. n=4-9, * p<0.05 vs 1R.    
Culture of CPCs in 2RJ hydrogels increased expression of Hey1, a downstream 
target of Notch1 signaling (p<0.05, n=4, Fig. 4.5A).  Interestingly, culture in 2% 
hydrogels with RJ promoted expression of the cardiac genes nkx2-5 (p<0.001, n=5), 
mef2c (p<0.05, n=8) and gata4 (p<0.05, n=6; Fig. 4.5B-D) while no changes in 
expression of the endothelial or smooth muscle genes was observed (n=5-7, Fig. 4.5E-
H).  No significant differences were observed in gene expression between CPCs in 







Figure 4.5:  Culture of CPCs in 2% hydrogels with RJ activates Notch1 signaling 
and promotes cardiac gene expression.  CPCs were cultured in 2% hydrogels (R, RS, 
RJ) for 48h and expression of (A) Notch1 downstream target, Hey1, (B) nkx2-5, (C) 
MEF2C, (D) GATA4, (E) VEGF receptor1 Flt1, (F) vWF, (G) sm22α and (H) sm α-actin 
was measured by qPCR. n=4-8, * p<0.05, *** p<0.001 vs 2R.  
E     F 




Low stiffness hydrogels promote endothelial gene expression in mouse embryoid 
bodies 
Mouse embryoid body-derived cells were cultured in low stiffness (1%) hydrogels 
for 48h.  A significant increase in expression of the VEGF receptor Flk1 (p<0.05), cell 
surface adhesion molecule PECAM1 (p<0.001) and smooth muscle myosin heavy chain 
Myh11 (p<0.01) was observed in cells cultured in 1% hydrogels containing RJ (n=3, 
Fig.4.6 A-C).  No expression of the cardiac marker Troponin T was observed. Culture in 
2% hydrogels containing RJ showed a trend towards increased cTnT expression (data not 
shown).  
 
Figure 4.6: Long term culture of mouse embryoid bodies (EBs) in 1% hydrogels 
with RJ promotes endothelial and smooth muscle gene expression.  Mouse EBs were 
cultured in 1% hydrogels (R, RS, RJ) for 1 week and expression of (A) VEGF receptor2 
Flk1, (B) PECAM1, and (C) smooth muscle Myosin Heavy chain Myh11 was measured 




RJ-mediated Notch1 activation augments growth factor production in CPCs 
Conditioned media was obtained from CPCs cultured for 48h in 1R, 1RS, 1RJ, 2R, 2RS 
and 2RJ hydrogels.  The secreted growth factors in the conditioned media were analyzed 
by an ELISA array.  No change in levels of VEGF, GM-CSF, IP10, bFGF and IGF1 were 
observed between CPCs in 1R and 1RJ hydrogels (n=6, p>0.05).  However, culture in 
1RJ hydrogels increased expression of SCF (p<0.01), IL6 (p<0.05) and PDGF (p=0.08, 
n=6, Fig 4.7 A-H).  
 
Figure 4.7: Angiogenic growth factor expression in CPC conditoned media.  CPCs 
were cultured in 1R and 1RJ hydrogels for 48h and the secreted growth factors, (A) IL6, 
(B) SCF, (C) IGF1, (D) PDGF, (E) VEGF, (F) GM-CSF, (G) IP10 and (H) bFGF, present 
in the conditioned media were analyzed by an ELISA array.  Higher levels of IL6, SCF 
and PDGF were observed in media from CPCs in 1RJ hydrogels compared with 1R 
hydrogels. * p<0.05, ** p<0.01, n=6, Student’s t-test. 
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To validate and determine the exact quantities of growth factors secreted, a 
growth factor-specific ELISA was performed.  As shown in Figure 4.8A, CPCs cultured 
in 1RJ hydrogels had a 43% increase in Platelet derived growth factor-BB (PDGF) 
production compared to 1R gels (p<0.05, Fig. 4.8A).  Less than 3pg of PDGF was 
present in the conditioned media from CPCs in 2R and 2RJ hydrogels (Fig. 4.8A).  The 
effect of this conditioned media on tube formation by rat cardiac endothelial cells (CECs) 
was analyzed.  As shown in Figure 4.8B, CECs formed more tubes and interconnections 
between cells when cultured in 1RJ conditioned media.  A significant increase in tube 
length was observed in CECs in 1RJ media when compared to 1R and 1RS (n=3, p<0.05, 
Fig. 4.8C).  The amount of stem cell factor (SCF) in conditioned media obtained from 
CPCs in 1R, 1RJ, 2R, and 2RJ hydrogels was determined by a SCF-specific ELISA.  As 
shown in Figure 4.8D, a 6% increase in SCF production was observed in 1RJ 
conditioned media compared to 1R (n=10, ns).  A 13% increase in SCF was observed in 








Figure 4.8:  Paracrine effects of Notch1 activated CPCs is stiffness dependent. (A) 
Higher PDGF levels present in conditioned media obtained from CPCs cultured for 48h 
in 1RJ compared to 1R hydrogels. * p<0.05, n=6, Student’s t-test. (B) Representative 
images of tube formation by rat cardiac endothelial cells (CECs) cultured in conditioned 
media obtained from 1R (top), 1RS (middle) and 1RJ (bottom). Scale bar 1mm.  (C) 
Quantification of CEC tube length.  A 3-fold increase in tube length is observed in CECs 
cultured in conditioned media obtained from CPCs cultured in 1RJ hydrogels. n=3, * 
p<0.05 vs 1R.  (D) Higher SCF levels present in conditioned media obtained from CPCs 
cultured for 48h in 2RJ compared to all other hydrogels. * p<0.05 vs 2R, # p<0.05 vs 1R, 





As Notch1 signaling is known to promote cell proliferation, CPCs were cultured 
in 1R, 1RS, 1RJ, 2R, 2RS and 2RJ hydrogels for 24 hours and cell proliferation was 
quantified by the extent of EdU incorporated DNA in cells by click-iT EdU assay.  As 
shown in Figure 4.9A, CPCs cultured in 2RJ hydrogel had a significant increase in EdU 
incorporated DNA indicative of proliferation compared to all other groups (n=3-5, 
p<0.05 vs 2RS and 1RJ; p<0.01 vs 2R; p<0.001 vs 1R).  The effect of conditioned media 
(2R, 2RS and 2RJ) on rat primary cardiomyocytes and H9C2 myoblast proliferation was 







Figure 4.9: Proliferative effects of Notch1 activated CPCs is stiffness dependent. (A) 
Increased EdU-incorporated DNA present in CPCs cultured in 2RJ compared to all other 
hydrogels.  * p<0.05, ** p<0.01 and *** p<0.001, n=3-5, One-way ANOVA.  Increased 
EdU-incorporated DNA present in rat primary adult cardiomyocytes (B, ** p<0.01 vs 2R, 
n=4) and H9C2 myoblasts (C, * p<0.05 vs 2RS, ** p<0.01 vs 2R, n=4) cultured in 2RJ 
compared to all other hydrogels. One-way ANOVA. 
 
A     B       C 
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As shown in Figure 4.9B, a significant increase in EdU incorporation is observed 
in primary adult cardiomyocytes cultured in 2RJ CPC conditioned media (n=5, p<0.01 vs 
2R).  A similar result was observed in H9C2 myoblasts (Fig. 4.9C, n=4, p<0.05 vs 2RS, 
p<0.01 vs 2R).   
Hydrogel concentration differentially regulates key signaling pathway target genes 
Expression levels of several signal transduction pathway targets in CPCs cultured 
in 1R or 2R hydrogels were analyzed by qPCR array.  CPCs in 1R hydrogels had higher 
expression of proinflammatory genes such as TNFα, TRAIL and IFNγ, MMP7 and 
CyclinD2 compared to CPCs in 2R hydrogels.  The downstream targets of Notch1- Hes5 
and Heyl were also increased indicative of Notch1 activation (Fig. 4.10A). 
Culture of CPCs in higher concentration hydrogel (2R) resulted in increase of the 
Notch1 target Hes1, the Notch1 ligand Jagged1 and γ-secretase interacting gene Herpud1 
(Fig. 4.10B).  Higher expression of i) antioxidant genes - glutathione reductase (Gsr), 
NAD(P)H dehydrogenase quinone 1 (Nqo1), Sequestosome 1(Sqstm1) and carbonic 
anhydrase 9 (Car), ii) PPAR targets - Glut1, Fatty acid transporter member 4 (Slc27a4) 
and long chain acyl-CoA synthetases- members 4 and 5(Acsl4, Acsl5) iii) Bone 
morphogenetic protein 2 (BMP2), iv) Wnt ligands- Wnt5A and Wnt1 inducible signaling 
pathway protein 1 (Wisp1), v) TGFβ targets -Cyclin-dependent kinase inhibitor 1B 
(Cdkn1b) and epithelial membrane protein 1 (Emp1), vi) NFκB target macrophage 
colony stimulating factor 1 (M-CSF) and vii) JAK/STAT inhibitor- Suppressor of 
cytokine signaling 3 (Socs3) and JAK/STAT target myeloid cell leukemia sequence 1 




Figure 4.10: Hydrogel concentration differentially regulates gene expression in CPCs.  
(A) Higher pro-inflammatory gene expression in CPCs cultured in 1R hydrogels 
compared to 2R.  (B) Increased cardioprotective gene expression in CPCs cultured in 2R 




4.2.6 CPC delivery in RJ hydrogels improves cardiac retention 
To analyze the extent of myocardial retention of the CPCs, DiR-labeled CPCs in 
SAP hydrogels (2R, 2RS, and 2RJ) were injected in 3 border zones around the infarct.  A 
time course in vivo imaging of the rats was performed to determine the fluorescent 
intensity in the hearts as readout of cardiac retention.  As shown in Figure 4.11A, CPCs 
in 2RJ hydrogels had a significantly higher % retention compared to CPCs in 2R and 2RS 
hydrogels until day 7 (n=5 per group, p<0.05 vs 2R at days 1,2,3 and 4; p<0.05 vs 2RS at 
days 4 and 7, two-way ANOVA).  A similar trend was observed until day 14.  




Figure 4.11:  Improved myocardial retention of CPCs in 2RJ hydrogels. (A)  
Quantification of myocardial retention over time.  Rats with intramyocardial injection of 
DiR labeled CPCs were imaged on days 0,1,2,3,4,7,10,14 and 21.  Increased retention of 
implanted CPCs is observed in 2RJ hydrogels compared to CPCs in 2R and 2RS. * 
p<0.05 vs 2R and ^ p<0.05 vs 2RS, n=5 per group, Two-way ANOVA. (B) 
Representative images of each group over time.  DiR-CPCs in 2R (top), in 2RS (middle) 
and in 2RJ (bottom). 
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CPC delivery in RJ hydrogels promotes cardiac repair 
The functional consequences of CPC implantation in 2R, 2RS or 2RJ hydrogels 
was investigated in rats subjected to experimental myocardial infarction.  Male CPCs in 
2% hydrogels containing empty, scrambled or Jag1 peptide (2R, 2RS, or 2RJ) were 
injected intramyocardially (i.m.) in 3 border zones in female rats following myocardial 
infarction.  Cardiac function was evaluated 21 days later by echocardiography and 
invasive pressure-volume hemodynamic measurements.   Ischemia/Reperfusion (IR) for 
30minutes significantly decreased ejection fraction of the hearts compared to sham 
operated animals.  Treatment with CPCs in 2RJ hydrogels significantly improved ejection 
function comparable to levels in sham operated animals as assessed by invasive 
hemodynamic analysis (Fig. 4.12A). No improvement in function was observed in 
animals treated with CPCs in empty (2R) or scrambled (2RS) hydrogels indicating the 
importance of Notch1 activation in improving function following infarction. A trend for 
improvement was observed in rats treated with CPCs in 2RJ hydrogels for the cardiac 
contractility indicator ±dP/dt (Fig. 4.12B).  Among other parameters of ventricular 
function, the significant decrease in stroke work, stroke volume and cardiac output 
following IR was reversed in rats treated with CPCs in 2RJ hydrogels (Fig. 4.12C, F and 
G).   End systolic volume (ESV), an indicator of cardiac contractility was elevated 
following IR and treatment with CPCs in 2RJ decreased it to levels comparable to sham 
operated rats (Fig. 4.12D).  No change in end diastolic volume (EDV) was observed (Fig. 

















Figure 4.12: Delivery of CPCs in 2RJ hydrogel improves cardiac function following 
MI.  (A) Pressure Volume Hemodynamic measurements of (A) ejection fraction (EF%), 
(B) dP/dT, (C) Stroke Work, (D) End Systolic Volume (ESV), (E) End Diastolic Volume 
(EDV), (F) stroke volume and (G) cardiac output in rats treated with CPCs in 2RJ 
hydrogels.  n=10-12, * p<0.05, **p<0.01, # p<0.001, One-way ANOVA and Tukey’s 
post test. 
F     G 
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To evaluate the potential mechanism behind the observed improvement in 
function, Picosirius Red staining of heart sections was performed.  Infarction resulted in a 
significant increase in cardiac fibrosis.  In comparison, treatment with CPCs in 2RJ 
hydrogel resulted in a significant decrease in fibrosis (p<0.05, n≥5, Fig. 4.13A, 
representative images in Fig. 4.13B). 
 
Figure 4.13:  Delivery of CPCs in 2RJ hydrogel decreases fibrosis.  (A) 
Quantification of % fibrosis in rat hearts on day 21 shows a significant increase in 
fibrosis following 30min of ischemia-reperfusion (orange bar).  Administration of CPCs 
in 2RJ attenuated this increase. * p<0.05, and # p<0.001 vs IR. n≥5 per group.  (B) 






Cardiac progenitor cells (CPCs) can be easily obtained from autologous sources 
and have shown promising outcomes in Phase I clinical trials in patients with 
cardiovascular disease.  However, lack of myocardial retention and specific soluble cues 
impedes successful regeneration.  Thus, hydrogel scaffolds that mimic cardiac tissue 
could provide an environment with appropriate mechanical and chemical cues to augment 
CPC function.    Stem cell function is regulated by growth factors, cytokines, cell-cell 
interactions and mechanical stimuli such as substrate stiffness, rigidity, shear stress, 
stretch and topography (134).  Stem cells are sensitive to mechanical properties of the 
environment such as stiffness of native tissue which varies from kilopascals to hundreds 
of megapascals throughout the human body.  Substrate stiffness has been shown to 
regulate specification of adult stem cells into different lineages depending on correlation 
with native tissue stiffness.  For example, Engler et al have shown that culture of MSCs 
on substrates with stiffness similar to brain, muscle and bone leads to differentiation into 
neural, myogenic and osteogenic phenotype, respectively (135).  Endothelial 
differentiation of cardiac precursor cells cultured on substrates with rigidity matching 
native cardiac tissue has also been reported (136).  Substrate stiffness has also been 
shown to affect human pluripotent stem cell derived cardiomyocyte contraction (137).  
These studies demonstrate control of stem cell fate and function through mechanical 
properties of the culture environment.  Here, we demonstrate for the first time that 
hydrogel-stiffness activates Notch1 signaling and regulates CPC gene expression and 




Several natural and synthetic materials have been investigated for use as cardiac 
scaffolds such as fibrin, collagen, PLGA, gelatin and hyaluronic acid (138).  However, 
local inflammation, toxic degradation products and large pore sizes have limited their 
widespread use (139).    Previous studies have shown that self-assembling peptide (SAP) 
hydrogels can be used to deliver growth factors (86, 140), cytokines (141) and cardiac 
stem cells (142) to the infarcted heart.  Moreover, the stiffness of these hydrogels and the 
concentration of the bioactive factor can be tuned to provide hydrogels with well-
regulated mechanical and biochemical properties.  These SAP hydrogels also recruit host 
endothelial cells and cardiomyocytes into the myocardium and promote 
neovascularization (94).  Implantation of CPCs in Insulin-like growth factor 1 (IGF1) 
containing SAP hydrogels has also demonstrated improved cardiac function following 
infarction in rats (54).  However, the precise mechanism by which cells are retained in 
the hydrogel is not clearly understood.  RADA16-II used in this study has no known cell 
adhesion motifs; so physical entrapment within the gel and appropriate pore size that 
allows for nutrient diffusion are plausible explanations for cell retention (85).  Moreover, 
the SAP hydrogels can be easily synthesized, have low immunogenicity (141), support 
cell survival and allow for addition of bioactive motifs (such as RJ), thus providing a 
platform for incorporation of cell adhesion motifs and varying peptide concentrations in 
future studies.  
The development of biomaterials in which signaling pathways critical for CPC 
function such as Notch1 can be incorporated is of great importance since CPCs are 
endogenously present in niches of defined composition (143, 144) and exert their 
reparative effects depending on environmental cues following injury, aging or disease 
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(31, 145-147).  The current work demonstrates that RJ-mediated Notch1 activation 
significantly influences cardiogenic gene expression and cardiac repair.  In vitro 3D 
culture of CPCs on RJ containing 1 or 2% hydrogels increased expression of Hey1, a 
downstream target of Notch1.  Interestingly, culture on lower stiffness 1% RJ hydrogels 
resulted in increased endothelial and smooth muscle gene expression.  However,  higher 
stiffness 2% RJ hydrogels promoted cardiac gene expression indicating the synergistic 
effect of hydrogel stiffness and Notch1 activation on cardiogenic gene expression in 
CPCs.  Recent studies have demonstrated the reliance of Notch activation on ligand-
mediated pulling force exerted on the notch extracellular domain (132).  This mechanical 
force leads to γ-secretase mediated cleavage and nuclear translocation of the NICD.  Such 
mechanotransduction-mediated notch activation has been attempted in this study using RJ 
containing hydrogels of varying stiffness.  These results also suggest that in vitro 3D 
culture in 1RJ or 2RJ hydrogels could pre-commit the CPCs towards the 
endothelial/smooth muscle or cardiac lineage respectively before in vivo delivery.  This 
is critical as previous studies suggest that the fibrotic infarct environment is less 
compliant and delivery of stem cells in a hydrogel provides an environment amenable to 
remodeling and repair (135, 148).  
Paracrine signaling could play a pivotal role in stem cell therapy as release of 
soluble factors by the transplanted cells can augment cardiac repair (149).  We examined 
the conditioned media obtained from in vitro 3D culture of CPCs for secreted factors.  
We observed the secretion of PDGF and SCF in the media of CPCs in 1RJ and 2RJ 
hydrogels respectively.  While the role of PDGF in promoting angiogenesis and SCF in 
regulating CSC migration is well known (150, 151), SCF has also been shown to promote 
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endothelial cell tube formation (152).  The conditioned media obtained from CPCs 
cultured in 1RJ hydrogels promoted cardiac endothelial cell tube formation indicating 
paracrine angiogenic benefits.  Matsuura et al have reported beneficial effects of CPC 
sheet transplantation in a mouse model of MI due to secreted factor- mediated 
angiogenesis.  Specifically, array analysis showed increased secretion of VCAM1, IL6, 
and IL4 among others with VCAM1 identified to be critical for cardiomyocyte survival 
and function (153).  Proteomic analysis of cardiosphere-derived cell secretome has also 
identified key factors that are differentially secreted compared to cardiomyocytes (154).  
These results suggest that differential soluble factor secretion by CPCs cultured in RJ 
hydrogels is stiffness dependent.  The increase in cardioprotective gene expression in 
CPCs in 2R hydrogels compared to 1R hydrogels and the increased pro-inflammatory 
gene expression in CPCs in 1R hydrogels led to the use of the 2R hydrogels in the in vivo 
studies.  
Notch1 signaling mediates several cellular processes such as cardiac 
embryogenesis, tissue regeneration, stem/progenitor cell proliferation and survival.  
Studies have shown that the effect of Notch1 activation is stem cell specific.  ESC 
differentiation requires Notch1 inhibition while Notch1 activation promotes cardiac gene 
expression in MSCs and CPCs (10, 68, 69).  Interestingly, mouse embryoid bodies 
cultured in the 1RJ hydrogels for 1 week had increased endothelial and smooth muscle 
gene expression indicating that 3D Notch1 activation results in a similar stiffness-
dependent gene expression in different stem/progenitor cells.  As Notch1 signaling has 
been shown to regulate stem cell proliferation, we examined CPC proliferation in the 
hydrogels.  Culture in 2RJ hydrogels increased the extent of EdU incorporated DNA in 
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the CPCs suggesting improved proliferative capacity on 3D culture in 2RJ hydrogels.  As 
culture in 2RJ hydrogels increased cardiac gene expression, we examined if the 
conditioned media increased cardiomyocyte proliferation.  Culture in 2RJ conditioned 
media increased adult rat cardiomyocyte proliferation.  Taken together, these results 
suggest that CPCs cultured in Notch1-activated hydrogels secrete growth factors that can 
exert paracrine benefits on cardiomyocytes and endothelial cells.   
Next, we examined if the positive effects of CPC cultured in 2RJ hydrogels 
translated to improvements in cardiac retention and function in a rat model of myocardial 
infarction.  Delivery of CPCs in 2RJ hydrogels led to sustained retention of ~80% of the 
implanted cells in the myocardium for 1 week.  Such high level of acute retention is 
significant as Terrovitis et al report  less than 20% retention of transplanted cardiac-
derived stem cells one week following administration in a rat myocardial infarction 
model (155).  As low engraftment of implanted stem cells in the heart impedes cardiac 
regeneration and repair, delivery in 2RJ hydrogels provides an environment for 
successful CPC engraftment.  However, as DiR signal loss over time and uptake of the 
lipophilic dye by other host cells could occur, CPC retention in the myocardium needs to 
be verified by approaches based on identifying the Y-chromosome+ CPCs in the heart 
tissue sections. 
As shown in figure 4.12, ejection fraction recovered to sham-operated levels in 
rats treated with CPCs in 2RJ hydrogels whereas all other treatment groups had 
persistently decreased ejection fraction.  We also assessed other metrics indicative of 
functional improvement through pressure-volume hemodynamics.  Measures of cardiac 
contractility such as stroke work and end systolic volume (ESV) were preferentially 
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improved in rats that received CPCs in 2RJ hydrogels.  New data from human clinical 
trials support the reparative potential of stem cell therapy for heart failure.  Moreover, c-
Kit
+
 CPCs can be easily isolated from cardiac biopsies even from patients with advanced 
heart failure (156).  Hence, the improvement in cardiac function, contractility and 
retention in the CPC in 2RJ group could translate into positive clinical outcomes in 
patients.  These studies need to be performed in large animal models of MI to be 
predictive of effects in humans.   
Taken together, we have shown that Notch1 activation is stiffness dependent, 
which differentially regulates cardiogenic gene expression in CPCs, and that delivery of 
CPCs in 2RJ hydrogels improves acute myocardial retention and hemodynamic function 
after MI.  Intramyocardial injection of CPCs in 2RJ hydrogels could be an efficient and 





NOTCH ACTIVATING HYDROGELS ATTENUATE CARDIAC 
DYSFUNCTION  
5.1 INTRODUCTION 
Myocardial infarction (MI) is a leading cause of death worldwide (1).  Occlusion 
of the coronary artery leads to MI characterized by local ischemia, myocyte apoptosis, 
fibrotic scar and irreversible tissue damage which progresses over time to heart failure.  
While current treatments such as pharmacological intervention and assistive device 
implantation salvage the injured heart acutely, heart transplantation is the most viable 
treatment option for patients with end-stage heart failure.  However, limited availability 
of donor hearts and side-effects of transplant-associated immunosuppression in patients 
with comorbidities has created the need for treatment alternatives.  Early infarct 
expansion leading to increased regional stress has been identified as a key factor that 
accelerates cardiac remodeling with poor prognosis (157).  Use of ventricular restraints 
that limit cardiac expansion and provide mechanical support in large animal models of 
MI has shown limited global remodeling (158).  However, the invasive surgical 
procedure required has limited clinical application.  To circumvent this, our group and 
others have investigated the use of injectable cell-free biomaterials to support cardiac 
function following MI by serving as tissue bulking agents and cell/growth factor delivery 
vehicles (72, 81, 159-162).  
Hydrogels are a class of biomaterials composed of hydrophilic polymers of 
natural or synthetic origin characterized by high water content that can provide support to 
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the damaged myocardium following MI.  A tissue compatible hydrogel is characterized 
by the ability to promote specific ligand-receptor interactions, host cell migration, 
minimal host inflammatory or foreign body response, controlled biofactor release and 
tunable degradation kinetics.   Hydrogels with diverse physical properties have been used 
in a variety of cardiac applications ranging from controlled delivery of drugs and small 
molecules to growth factors and stem cells (163).  For use in the infarct environment, 
hydrogels with chemical and mechanical properties of native tissue are needed for 
successful cardiac regeneration.   
Self-assembling peptides (SAP) are a class of hydrogels composed of alternating 
hydrophilic and hydrophobic aminoacids that self-assemble at physiologic pH and 
osmolarity to form a hydrogel.  Two well-studied types of SAPs are RADA16-I (AcN-
(RADARADA)2-CNH2) and RADA16-II (AcN-(RARADADA)2 -CNH2) (164).  
RADA16-II has been used in this study.  To attenuate the viable myocardium lost after 
MI, cardioprotective cues have been delivered through SAP to the infarcted heart.  For 
example, using streptavidin-biotin conjugation system with SAP, sustained delivery of 
IGF-1 to the infarcted rodent heart has resulted in improved cardiomyocyte survival 
(160).  Sustained PDGF delivery in SAP hydrogels has led to improved cardiac function 
and limited adverse remodeling after MI (126).  Delivery of VEGF in SAP hydrogels to 
the infarcted rat and pig heart following MI has promoted tissue repair and restored 
cardiac function (86).  Dual delivery of PDGF and FGF in SAP hydrogels improved 
cardiac function of the infarcted rat heart compared to either growth factor alone (140).  
These studies demonstrate the potential of SAPs to serve as instructive biomaterials for 
cardiac applications.   
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Notch1 signaling is known to play a critical role in cardiac development and in 
the survival, cardiogenic lineage commitment, and differentiation of cardiac 
stem/progenitor cells (10, 58, 64).  These varied critical roles played by Notch signaling 
have led to research on identifying ways to activate and control Notch signaling in vitro 
and in vivo.  This has been achieved through soluble Notch ligands, over-expression of 
the active Notch intracellular domain in cells, ligand immobilization on tissue culture 
polystyrene surfaces and development of biomaterials with immobilized notch ligands.  
While soluble Delta/Jagged ligands also allow for ligand-receptor interaction, the lack of 
ligand-mediated receptor endocytosis may antagonize downstream signal activation 
(132).  As overexpression of the receptors or ligands does not represent clinically 
translatable systems, ligand immobilization strategies have been attempted for controlled 
induction of Notch signaling.   
In this study, we functionalized self-assembling peptide (SAP) hydrogels with a 
peptide mimic of the Notch1 ligand Jagged1 (RJ) to evaluate the effect of hydrogel-
mediated Notch activation in the myocardium in a rat model of myocardial infarction.    
Endogenous progenitor cells and other resident cells are known to migrate to the infarct 
site due to the signals present in the infarct and in response to the presence of SAP (94, 
165, 166).  Moreover, following an infarction, an increase in levels of Notch activation 
along with increases in downstream targets and corresponding ligand expression has been 
observed (67).  So we sought to include a ligand to promote Notch signaling in the host 
cells and this study demonstrates the potential therapeutic benefit of functionalizing SAP 





Delivery of 2RJ hydrogel improves cardiac function 
The functional consequences of implantation of 2R or 2RJ hydrogels were 
investigated in rats subjected to experimental myocardial infarction.  Two percent 
hydrogels containing empty or Jag1 peptide (2R or 2RJ) were injected intramyocardially 
(i.m.) in 3 border zones in female rats following myocardial infarction.  Cardiac function 
was evaluated 21 days later by echocardiography and invasive pressure-volume 
hemodynamic measurements.   Ischemia/Reperfusion for 30 minutes significantly 
decreased ejection fraction of the hearts when compared to sham operated animals.  
Treatment with 2RJ hydrogels significantly improved ejection function comparable to 
levels in sham operated animals as assessed by invasive hemodynamic analysis (Fig. 
5.1A). No improvement in function was observed in animals treated with empty (2R) 
hydrogel indicating the importance of Notch1 activation in improving function following 
infarction. Improvement was also observed in rats treated with 2RJ hydrogels for the 
cardiac contractility indicator +dP/dt (Fig. 5.1B).  Among the other parameters of 
ventricular function, the significant decrease in stroke work, stroke volume and cardiac 
output following IR was reversed in rats treated with 2RJ hydrogels (Fig. 5.1C, D and 
E).   End systolic volume (ESV), an indicator of cardiac contractility was elevated 
following IR and treatment with 2RJ hydrogel decreased it to levels comparable to sham 
operated rats (Fig. 5.1F).  No change in end diastolic volume (EDV) was observed (Fig. 
5.1G).  The cardiac compliance was also restored to sham levels on treatment with 2RJ 





Figure 5.1: Delivery of 2RJ hydrogel improves cardiac function following MI.  
Pressure-volume hemodynamic measurements of (A) ejection fraction (EF%), (B) 
±dP/dT, (C) Stroke Work, (D) Stroke Volume, (E) Cardiac Output, (F) End Systolic 
Volume (ESV), (G) End Diastolic Volume (EDV), and (H) compliance.  n≥5/group, * 




To evaluate a potential mechanism behind the observed improvement in function, 
Picosirius Red staining of heart sections was performed.  Infarction resulted in a 
significant increase in cardiac fibrosis. In comparison, treatment with 2RJ hydrogel 
resulted in a significant decrease in fibrosis (p<0.05, n=5, Fig. 5.2A).  Representative 




Figure 5.2:  Delivery of 2RJ hydrogel decreases fibrosis.  (A) Quantification of % 
fibrosis in rat hearts on day 21 shows a significant increase in fibrosis following 30min of 















increase. * p<0.05, and # p<0.001 vs IR.  n=5 per group.  (B) Representative images of 
heart sections stained with Pico-Sirius Red. Scale bar 1mm. 
 
5.3 DISCUSSION 
Delivery of cell-free hydrogel therapy has resulted in improvement in cardiac 
function in animal models of MI through improved mechanical support and beneficial 
effects of delivered bioactive cargo (167).  Interest in these approaches is high due to 
relative ease of clinical translation, high reproducibility and potential for off-the-shelf 
availability.  As activation of Notch signaling known to occur following MI has been 
shown to be cardioprotective, our objective was to augment Notch signaling in the host 
myocardium using a cell-free SAP hydrogel containing the Notch ligand RJ.  As shown 
in figure 5.1, ejection fraction recovered to sham-operated levels in rats treated with 2RJ 
hydrogels whereas treatment with 2R hydrogel had persistently decreased ejection 
fraction comparable to untreated infarcted rats.  We also assessed other metrics indicative 
of functional improvement through pressure-volume hemodynamics.  Measures of 
cardiac contractility such as stroke work and end systolic volume (ESV) were 
preferentially improved in rats that received 2RJ hydrogels.  These results demonstrate 
that hydrogel immobilized Notch1 ligand improves cardiac function in a rat model of MI.   
These results are in agreement with other studies that have examined the effect of 
Notch activation in the infarcted heart.  Specifically, activation of Notch signaling in 
cardiac progenitor cells (CPCs) is known to promote cardiomyogenic differentiation of 
CPCs (10).  Activation of Notch signaling by hepatocyte growth factor (HGF) in the 
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border zone after infarction is known to be cardioprotective by promoting cardiomyocyte 
survival, cell cycle reentry and improving cardiac function (67).  Recent studies on Notch 
activation using immobilized ligands show that substrates immobilized with full length 
Jagged-1/Fc receptor chimeric protein activate Notch signaling in a ligand density 
dependent manner (168).  Such systems have also been used to direct differentiation of 
hematopoietic progenitors into T-cells using microbeads functionalized with the Notch 
ligand Dll4 (169).   
Delivery of 2RJ hydrogel also decreased fibrosis significantly compared to 
untreated infarcted rat hearts.  Recently, the role of Notch activation in regulating fibrotic 
response of the heart has been investigated.  Studies demonstrate the inhibitory effect of 
Notch activation on cardiac fibroblast-myofibroblast transformation which is critical for 
initiation of fibrosis (170).  Moreover, Notch signaling has been shown to decrease 
cardiac fibrosis and promote cardiac progenitor cell proliferation in a mouse model of 
cardiac pressure overload (171).  Taken together, Notch activation plays a vital role in 
regulating the fibrotic and regenerative responses of the infarcted heart and delivery of 
2RJ hydrogels could modulate these responses. 
However, to clearly delineate the effects of 2RJ hydrogel, the potential effects on 
endogenous CPCs, myocyte survival and neovascularization need to examined.  As 
Notch activation has been shown to regulate the balance between fibrosis and 
regeneration, the extent of migration of fibroblasts and endogenous CPCs into the 
infarcted region merits investigation.  Moreover, as delivery of SAP hydrogel has been 
shown to promote migration of endothelial and smooth muscle cells into the hydrogel 
(94), the extent of such migration, Notch activation in these cells and angiogenesis 
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requires further study.  These studies also need to be performed in large animal models of 
MI to be predictive of effects in humans.  The improvement in cardiac function and 
contractility coupled with decreased fibrosis in the 2RJ group could translate into positive 
clinical outcomes in patients.  Intramyocardial injection of 2RJ hydrogels could be an 





SUMMARY AND FUTURE DIRECTIONS 
Heart failure is the leading cause of death worldwide.  In 2013, the American 
Heart Association estimated that one American will die of cardiovascular disease every 
39 seconds. While heart transplantation is the most viable treatment option, the limited 
availability of donor hearts has necessitated the search for treatment alternatives such as 
the use of adult stem cells for cardiac repair and regeneration.  Following myocardial 
infarction (MI), the inflammatory cardiac microenvironment, limited survival of 
stem/progenitor cells, myocardial scarring and fibrosis affect cardiac regeneration.  This 
dissertation examines adult stem cell based approaches for cardiac regeneration by 
studying the effect of i) H2O2- mediated oxidative stress on mesenchymal stem cells, ii) 
Notch1 activation in cardiac progenitor cells using a self-assembling peptide hydrogel 
containing the Notch1 ligand mimic RJ in vitro and functional consequences in a rat 
model of MI.  Through these approaches, the central hypothesis that modulation of stem 
cell response using cues such as oxidative stress and activation of Notch1 signaling can 
improve functional outcome following myocardial infarction has been studied. 
6.1 OXIDATIVE STRESS INFLUENCES MESENCHYMAL STEM CELLS 
Chapter 3 describes how oxidative stress influences cardiogenic gene expression 
in mesenchymal stem cells (MSCs).  Levels of oxidative stress are elevated in the 
infarcted heart.  Delivery of MSCs to the infarcted heart has resulted in modest 
improvements in function.  In this study, we sought to determine if oxidative stress can 
regulate MSC gene expression.  MSCs were treated with either H2O2 for 1 week (0-
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100µM) or with Glucose oxidase (GOX, 0-5 mU/ml) for 48h to represent pulsed and 
continuous exposure to oxidative stress respectively.  We found a threshold effect of 
100µM H2O2 or 5mU/ml GOX in increasing cardiac and endothelial gene expression in 
MSCs through Notch1 signaling.  Similar results were obtained with another adult stem 
cell, cardiac progenitor cell (CPC).   
Based on these results, pre-conditioning adult stem cells with oxidative stress 
stimuli could improve therapeutic benefit following transplantation in the infarcted heart 
through increased cardiac differentiation.  To examine this possibility, work in the Davis 
lab has also focused on examining the effects of H2O2 preconditioned CPCs on cardiac 
function in a rat model of experimental infarction.  Delivery of H2O2 preconditioned 
CPCs in self-assembling peptide (SAP) hydrogels to the infarcted rat heart led to 
improvement in function, decreased fibrosis, and increased capillary density.  These 
results suggest that response to oxidative stress is conserved among the adult stem cell 
types- MSCs and CPCs and could be developed in a therapeutic pre-conditioning 
strategy.  However, exposure of rat MSCs to H2O2 has been shown to decrease cell 
adhesion and spread which was overcome by co-treatment with the reactive oxygen 
species scavenger, N-acetyl cysteine (29).  Although we did not observe changes in cell 
adhesion to tissue culture flasks, the dose and duration of treatment of stem cells with 
H2O2 needs to be optimized for in vivo applications.  As more robust increases in cardiac 
gene expression were obtained on treatment of MSCs with GOX, MSCs over-expressing 
GOX can be generated and therapeutic efficacy tested in vivo.  Recent studies in primary 
glial cells show that the continuous exposure to H2O2 results in more  pronounced effects 
than pulses of H2O2 (172). 
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In vivo delivery of these cells will demonstrate the effect of continuous H2O2 
generation on cardiac function.  As high levels of H2O2 cause cell death, the extent of 
intracellular H2O2 generated in GOX-overexpressing cells needs to be determined and 
can be regulated under an inducible promoter.  As SAP hydrogels containing RJ promote 
Notch1 signaling (described in Chapters 4 and 5), H2O2-preconditioned MSCs can be 
delivered in RJ containing SAP hydrogels to activate Notch1 signaling in MSCs and in 
the host cells that may infiltrate the hydrogel in a rat model of myocardial infarction.  
These studies will explore the potential of synergistic Notch activation on improving 
cardiac function following infarction. 
6.2 NOTCH ACTIVATION IN CARDIAC PROGENITOR CELLS 
Notch signaling plays an important role in cardiac development, stem cell survival 
and differentiation.  Mechanical force exerted by ligand bound to Notch1 receptor is 
essential for activation of Notch1 signaling, thus we designed a 3D self-assembling 
peptide hydrogel that incorporated a peptide mimic of the Notch1 ligand Jagged1 (RJ) to 
engineer stem cell response to Notch1 signaling.  As described in Chapter 4, utilizing a 
reporter cell line, we demonstrated a dynamic effect of hydrogel stiffness and presence of 
Notch1 ligand RJ on Notch1 activation.  These results can be studied in more detail using 
force measurements of the ligand RJ- Notch1 interaction on substrates of varying 
stiffness (173).  We also found that hydrogel stiffness-dependent Notch1 activation 
differentially regulated cardiogenic gene expression in rat CPCs.  Culture of CPCs in RJ-
containing hydrogels also exerted paracrine effects on endothelial cells and myocytes in 
vitro.  However, as Notch signaling is involved in a multitude of cell developmental 
stages, determining the effect of Notch activation at a single set time point may not 
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reflect its actual temporal effect and additional time course experiments could be 
performed in vitro. 
In rats subjected to MI, intramyocardial delivery of CPCs in 2RJ hydrogels 
promoted cardiac repair through increased ejection fraction, stroke work and decreased 
fibrosis on day 21 after treatment.  The mechanism by which the CPCs in 2RJ hydrogels 
cause improvement in cardiac function needs to be elucidated.  In previous studies, 
differentiation of CPCs into cardiac cells has been reported (10).  To that end, 
immunohistochemistry of heart sections will show the origin of any newly formed cells 
by co-expression of Y-chromosome or Luciferase with proteins specific for cardiac, 
endothelial and smooth muscle cells.  Other potential effects on vascularization, 
inflammatory cell infiltration, myocyte proliferation, endogenous CPC recruitment also 
need to be investigated.  The differential effects of Notch1 activation in hydrogels of 
varying stiffness can be explored in vivo by transplanting cells in 1% hydrogels (1R, 1RS 
and 1RJ).  The CPCs in hydrogels could also be transplanted 4 weeks after MI to 
represent a more clinical situation through double survival surgeries in rats.  Currently, 
human CPCs have been successfully isolated from human heart explants and expanded in 
the Davis laboratory.  Efforts are ongoing to extend the present study to examine the 
effect of SAP hydrogel mediated Notch1 activation on human CPCs in vitro and 
determine the effects in vivo in a nude rat model of myocardial infarction.   
6.3 HYDROGELS FOR NOTCH ACTIVATION 
 As described in Chapter 5, delivery of a peptide mimic of the Notch1 ligand 
Jagged1, RJ in a 2% SAP hydrogel (2RJ) to the infarcted rat heart attenuated cardiac 
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dysfunction and decreased cardiac fibrosis.  The SAP hydrogel was chosen to provide 
cues for Notch activation because i) mechanical properties of the SAP can be tuned to 
match the host myocardium, ii) the peptide can be reproducibly synthesized chemically, 
iii) the ligand density can be regulated and iv) acellular hydrogel systems are more 
clinically translatable.  The mechanism by which the 2RJ hydrogels improve cardiac 
function following MI needs further investigation.  Potential mechanisms to examine 
include extent of vascularization (capillary density, vessel formation), recruitment of 
endogenous CPCs, decreased apoptosis, increased survival of cardiomyocytes and 
decreased fibroblast activation.   
Many acellular biomaterials improve cardiac function by providing mechanical 
support as tissue bulking agents.  Both the 2R and 2RJ hydrogels have the same elastic 
moduli and swelling ratio.  But the lack of functional improvement in 2R hydrogel-
treated rats shows that mechanical support of the infarcted heart does not explain the 
observed results. To demonstrate the involvement of Notch signaling in the observed 
functional improvement, chemical Notch inhibitors such as DAPT (N-[N-(3,5-
Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester) may be given to rats before 
hydrogel treatment.  Also, Notch activation in host cells can be examined by 
immunohistochemistry for NICD.  These experiments will clearly delineate the role of 
2RJ hydrogels in activating Notch in the myocardium. 
It is interesting to note that improvement in cardiac function was observed after 
intramyocardial injection of CPCs in 2RJ hydrogels or 2RJ hydrogels without CPCs.  
However, the mechanism by which both treatment groups improve function could be 
different.  Improvement in function with CPCs in 2RJ hydrogels may result from cardiac 
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differentiation of transplanted cells and paracrine benefits of secreted growth factors.  In 
contrast, the 2RJ hydrogels may augment the endogenous healing response by promoting 
proliferation of endogenous c-Kit
+
 CPCs and cardiomyocytes.  These effects can be 
distinguished by long term follow up studies where presence of CPCs may be more 
beneficial.   
Timing of hydrogel injection is also critical.  In the current study, hydrogels were 
injected immediately post-MI.  Reports suggest that effects of acellular hydrogels are 
most pronounced when injected immediately post-MI (167).  Double survival studies in 
rat with hydrogel treatment after infarct stabilization may result in different outcomes.  
The current study can also be extended to a pig model of MI.  SAP mediated delivery of 
VEGF to the infarcted pig heart did not lead to an inflammatory response (86).  Such 
large animal studies could pave the way for clinical translation of 2RJ hydrogels to treat 
patients with MI. 
6.4 PERSPECTIVE 
 The occurrence of 1 death every 39 seconds due to cardiovascular disease (CVD) 
provides a strong impetus to find treatment alternatives for patients with CVD.  Adult 
stem cell therapy has emerged as a therapeutic option with promising results in pre-
clinical and Phase I clinical trials.  While extensive research has produced large 
advancements in the field, the type of stem cell, source, dose, route of delivery, time of 
injection and delivery of additional cell survival cues have to be clearly established for 
large scale clinical translation. This dissertation was an attempt at developing a stem cell 






A.1 CELL CULTURE 
Mesenchymal stem cell isolation-Mesenchymal stem cells were obtained from the 
femur and tibia of adult male Sprague-Dawley rats by Percoll density gradient 
centrifugation and adherence to tissue culture flasks.  MSCs from passages 2 to 4 
cultured on Mimimal Essential Media alpha (MEMα; Hyclone) supplemented with 20% 
Fetal Bovine Serum (Hyclone), L-Glutamine (Cellgro) and 100U Penicillin-Streptomycin 
(Invitrogen) were used.   
Cardiac progenitor cell isolation- Cardiac progenitor cells (CPCs) were isolated from 
the hearts of adult male Sprague-Dawley rats by selection of c-Kit
+
 cells with anti-cKit 
antibody (H-300, Santa Cruz) coated magnetic beads (Dynal)  as previously described 
(31).  
Media and Cell culture:  The mouse embryoid bodies were cultured in DMEM/F12 
containing 10% FBS, 1X Penicillin-Sterptomycin and L-Glutamine.  The CHO cells with 
Notch1 responsive YFP expression were cultured in Alpha MEM containing 10% FBS, 
1X Penicillin-Sterptomycin, L-Glutamine, Zeocin (400 µg/ml), Blasticidin (10 µg/ml) 
and Geneticin (600 µg/ml).  The rat cardiac endothelial cells were cultured in low glucose 
DMEM media (GIBCO) supplemented with 10% FBS, 50µg/mL endothelial cell growth 
supplement (Sigma E2759) and 1% 100X MEM Non-essential amino acids solution 
(GIBCO). The primary rat cardiomyocytes were isolated from rat hearts and cultured as 




A.2 STEM CELL CHARACTERIZATION 
Characterization of MSCs and CPCs- The surface expression of c-Kit (H-300, 
SantaCruz), CD45 (Invitrogen), CD34 (sc-7324, SantaCruz), CD73 (#551123, 
BDPharmingen), CD90 (#554898, BDPharmingen) and CD105 (bs-0579R, Bioss) in 
MSCs and expression of c-Kit, the transcription factors nkx2-5 (sc-14033, SantaCruz) 
and gata4 (sc-9053, SantaCruz) and the Notch1 Extracellular domain (NECD, Millipore) 
in CPCs was determined by flow analysis using a FACSCalibur (Becton Dickinson).  The 
isotypes of each antibody served as the negative control. 
Trilineage differentiation of MSCs- To determine the trilineage differentiation capacity, 
the MSCs were cultured in adipogenic (Cat# SR811D250, Amsbio), osteogenic (Cat# 
SR417D250, Amsbio) or chondrogenic (Cat# SC00B5-2, VitroBiopharma) media for 21 
days with media replenishment every 3 days.  The MSCs were also cultured for 1 week ± 
100µM H2O2.  To demonstrate adipogenic differentiation, the cells were stained with 
0.3% Oil Red O (Cat# O0625, Sigma) in isopropanol for 30min and rinsed with PBS.  
For osteogenic differentiation, the cells were stained with 1% Alizarin Red (Cat# 500-4, 
RiccaChem) for 15min.  For chondrogenic differentiation, cells were stained with 0.5% 
Toluidine Blue O in PBS (Cat# 198161-5G, Sigma).  The stained cells were imaged 
under a Phase contrast microscope (Olympus). 
 
A.3 IN VITRO EXPERIMENTS 
Induction of oxidative stress in MSCs and CPCs- To induce acute oxidative stress, 
MSCs or CPCs were cultured in serum-free media with Insulin/Transferrin/Selenium 
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(ITS) containing i) H2O2 (0-100µM; Fisher Scientific) for 1 week or ii) Glucose oxidase 
(0-5mU/ml; Sigma) for 48h.  Media was replenished every day with fresh media with or 
without H2O2.  MSC and CPC growth media contains 5.5mM and 10mM glucose 
respectively and addition of GOX results in continuous generation of H2O2. 
3D culture of cells in hydrogels:  The cells (CPC, CHO, mEB) were embedded in the 
different hydrogels (1R, 1RS, 1RJ, 2R, 2RS, 2RJ) with a 100µl total volume for 48h in 
Transwell cell culture insets (Millicell 0.4µm, PICM01250).  The treatment media 
consisted of base media with ITS supplement (Cellgro 25-800-CR), 1X Penicillin-
Sterptomycin and L-Glutamine. 
Chemical inhibition of Notch signaling- MSCs were treated with a γ-secretase inhibitor 
IX DAPT (N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycinet-Butyl Ester, 
Calbiochem, 10µM) every day for 1 week to inhibit Notch1 activation in MSCs ± H2O2.  
On day 7, RNA and protein was harvested for subsequent qRT-PCR and Western 
Blotting respectively. 
siRNA mediated knockdown of Notch1- To determine the optimal transfection reagent, 
MSCs were transfected with 100nM mock siRNA labeled with Cy3 for 48h using 
oligofectamine (Life Technologies), HiPerfect (Qiagen), or Lipofectamine RNAimax 
(Life Technologies) according to the manufacturer’s instructions.  The transfection 
efficiency was determined by flow analysis (FACSCalibur, Becton Dickinson) and 
fluorescent microscopy (Nikon).  To knockdown Notch1 expression in MSCs, the cells 
were transfected with 25nM of either QIAgen Allstar Negative control siRNA (siNC) or 
QIA siNotch1 (cat# S101920730) with oligofectamine (Life Technologies) according to 
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the manufacturer’s instructions.  After 48h, RNA and protein was harvested for 
subsequent qRT-PCR and Western Blotting respectively. 
Protein expression- MSCs were treated with or without 5mU/ml GOX for 48h.  The 
protein expression of α-MHC (ab50967, abcam), Flt1 (ab32152, abcam) and smooth 
muscle α-actin (SAB250093, Sigma) was determined by flow analysis using a 
FACSCalibur (Becton Dickinson).  Primary antibodies were used at 1:300 and 
appropriate secondary antibodies were used at 1:500 with isotype controls. 
Measurement of NICD- Total protein was isolated from the organic phase of Trizol 
extraction.  Equal amounts of protein were loaded on 4-15% SDS-PAGE gradient gel 
(Bio-Rad).  Following transfer, the nitrocellulose membrane was probed with anti-Notch 
intracellular domain (Cell Signaling) antibody.  A horseradish peroxidase conjugated 
goat anti-rabbit secondary antibody was used (Bio-Rad) and chemiluminiscent signals 
were obtained on a Kodak Imager Station 4000MM Pro (Carestream Molecular Imaging). 
NICD protein levels were normalized to GAPDH (Santa Cruz).  
ELISA for In Vitro Growth factor Expression- CPCs were cultured in the different 
hydrogels (1R, 1RS, 1RJ, 2R, 2RS, 2RJ) for 48h.  The conditioned media was screened 
for secreted growth factors using a custom array (Signosis, USA) according to the 
manufacturer’s directions. Growth factors of interest were confirmed by specific ELISAs 
(SCF, PDGF; Signosis). All immunosorbent measures were analyzed based on a standard 
curve and normalized to initial cell number.  
Tube formation- The rat cardiac endothelial cells were cultured in 1:1 CPC conditioned 
media and low serum endothelial growth media for 24h.  The cells were then cultured on 
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Geltrex (Life Tech) for 8h and stained with calcein.  The tube formation was imaged 
using a fluorescent microscope (Olympus) and tube length quantified using ImageJ. 
 
A.4 GENE EXPRESSION AND PCR 
as described in (175).  Quantitative real time PCR was performed on a StepOne Plus real 
time PCR system (Applied Biosystems) using specific primers for the cardiogenic and 
Notch1 related genes (see Table 1).  Gene expression data was normalized to GAPDH in 
the H2O2 treated MSCs and in all CPCs and to 18S in the GOX treated MSCs.  GAPDH 
Table 1: List of Primers 
Gene Forward Primer (5’ to 3’) Reverse primer (5’ to 3’) 
Flk1               GCCAATGAAGGGGAACTGAA
GAC  
TCTGACTGCTGGTGATGCTGTC 
Flt1 CCACTTCTGTCTTGCCACACA CCAACCAATTAAGACCTTCTG 
vWF CCCACCGGATGGCTAGGTATT GAGGCGGATCTGTTTGAGGTT 
α-MHC AACGCCCAAGCCCACTTGAA CATTGGCACGGACTGCGTCA 
Troponin I CCAGGAATCTGCAATCCCATT CCGCATCGCTGCTCTCA 
Gata4 ACCTGCTACAGCAGGGTTGGT TTCTAGCACAACTGCAAGCATG
GC 
Nkx2-5 CAAGTGCTCTCCTGCTTTCC GGCTTTGTCCAGCTCCACT 








Hey1 CCGCTTCGTGTTCGCCTGGT TGCTGCCTGTGAGGGTGTCG 
Hes5 ACCGCATCAACAGCAGCATT AGGCTTTGCTGTGCTTCAGGT 
Vimentin CCCAGATTCAGGAACAGCAT CACCTGTCTCCGGTATTCGT 
FSP1 GAGGAGGCCCTGGATGTAAT CTTCATTGTCCCTGTTGCTG 









Mef2c TaqMan MGB Rn01494046_n1 
Jagged1 TaqMan MGB Rn00569647_n1 
β-actin TaqMan VIC MGB 4352340E 
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is a gene involved in glucose metabolism and as addition of Glucose oxidase (GOX)  
alters the glucose levels in the media, 18S and not GAPDH was used as the house 
keeping gene for GOX studies. 
PCR array- Based on the manufacturer’s instructions, the Qiagen Rat Notch PCR Array 
PARN-059A was used to analyze gene expression in MSCs treated with or without 
5mU/ml GOX. 
 
A.5 HYDROGEL CHARACTERIZATION 
Design of the hydrogel-ligand system- The self-assembling peptide RADA 16-II (H2N-
RARADADARARADADA-OH) was generated with a 7 glycine linker following the 
terminal alanine, followed by the active sequence of the Notch ligand Jagged-1 (H2N-
CDDYYYGFGCNKFCRPR-OH) to create the final peptide RJ shown in Figure A1. As a 
control, the Jagged1 portion was replaced with the scrambled sequence (H2N-
RCGPDCFDNYGRYKYCF-OH) to create the final RS peptide containing the same 
residues. RJ or RS was combined with RADA in a ratio of 1:10 to ensure the extra 




Figure A1: Schematic of the hydrogel-ligand system 
 
 
AFM Modulus Testing: Using an MFP-3D-BIO atomic force microscope (Asylum 
Research; Santa Barbara, CA), samples were probed under fluid conditions using sucrose 
buffer.  A 15µm bead tipped-silicon nitride cantilever (Bruker, Camarillo, CA) was 
used.  Cantilever spring constants were measured prior to sample analysis using the 
thermal fluctuation method, with nominal values of 20-30 mN/m.  The force-indentation 
curve was obtained for each measurement and then analyzed with a Hertzian model for a 
spherical tip (Wavemetrics, IgorPro) from which the Young’s modulus was 
calculated.  The sample Poisson’s ratio was assumed as 0.5, and the deflection set point 
was 10 nN. 
Swelling ratio:  The hydrogels were created in a 100µl total volume and allowed to swell 
in sucrose solution.  After 24h, the wet weight of the gels was measured.  The gels were 
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then lyophilized and the dry weight noted.  Swelling ratio was calculated as the (wet 
weight- dry weight)/wet weight. 
 
A.6 IN VIVO EXPERIMENTS 
In vivo imaging: Rats were subjected to 30minutes of Ischemia/Reperfusion (IR).  CPCs 
were labeled with DiR as per the manufacturer’s instructions (Life Technologies).  About 
1e6 DiR-labeled CPCs in the different hydrogels (2R, 2RS and 2RJ) were injected in 3 
areas in the border zone surrounding the infarct (n=5/group).  The rats were imaged on 
days 0, 1, 2, 3, 4, 7, 10, 14 and 21.  The fluorescent intensity in the rat hearts due to the 
DiR- labeled CPCs was quantified as % retention (100% on day 0) over time. 
Myocardial Infarction, Cell Injection, and Functional Evaluation 
Myocardial infarction was performed in female adult Sprague Dawley rats (Charles River 
Laboratories) in a randomized double-blinded manner. Briefly, the rats were 
anaesthetized (1-3% isoflurane), intubated and heat exposed by separation of ribs.  The 
left anterior descending (LAD) coronary artery was ligated for 30 minutes.  During 
reperfusion, CPCs in hydrogels (40µl volume, 31G Ultra-Fine short syringe, BD) were 
injected into the myocardium at 3 border zones.  Cardiac function was evaluated 21 days 
after treatment by echocardiography (Acuson Sequoia 512 with a 14 MHz transducer) 
and invasive pressure-volume hemodynamics (Millar Instruments) to assess the 
functional effects of each cell therapy. All functional evaluations were conducted and 
analyzed by investigators blinded to the animal’s treatment group. The rats were 





Picosirius Red staining 
The hearts were fixed in 4% paraformaldehyde, dehydrated in ethanol, embedded in 
paraffin, and sectioned at 5µm thickness.  The tissue sections were dewaxed in Histoclear 
followed by a series of washes in ethanol and stained with pico-sirius red solution for 1 
hour (Sigma).  The sections were washed in acidified water and ethanol and mounted 
with resinous medium (Histomount).  Images of the entire heart section were taken at 
2.5x magnification on a bright field microscope (Olympus) and tiled together using 
Adobe Photoshop.  The % fibrosis was quantified using Image J as the ratio of fibrotic 
tissue (stained red) to total tissue. 
 
A.8 STATISTICS 
Statistical analysis- All data are expressed as mean + SEM.  To determine significance, 
either a One-way or Two-way analysis of variance (ANOVA) was done followed by the 
appropriate post-hoc test, or a Student’s t-test was performed using GraphPad Prism5.  A 
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